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The molecular mechanisms of apoptosis are evolutionarily-conserved with
caspases being the chief executioners of this process.  Though key regulators of
apoptosis, including caspases, inhibitor of apoptosis (IAP) proteins, and IAP antagonists
exist in both mammals and flies, there are reportedly mechanistic differences in the way
the apoptotic process is executed. One of the differences pertains to the importance of
mitochondrial permeabilization for caspase activation.  Herein, we demonstrate that
dOmi, a Drosophila homologue of the serine protease Omi/HtrA2, is a developmentally-
regulated mitochondrial intermembrane space protein that undergoes processive cleavage
in situ to generate two distinct inhibitor of apoptosis (IAP) binding motifs.  Depending
upon the pro-apoptotic stimulus, mature dOmi is then differentially released into the
cytosol, where it binds selectively to the baculovirus IAP repeat 2 (BIR2) domain in
Drosophila IAP1 (DIAP1) and displaces the initiator caspase DRONC.  This interaction
alone, however, is insufficient to promote apoptosis, as dOmi fails to displace the effector
caspase DrICE from the BIR1 domain in DIAP1.  Rather, dOmi alleviates DIAP1
inhibition of all caspases by proteolytically degrading DIAP1 and induces apoptosis both
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in cultured cells and in the developing fly eye.  Thus, we demonstrate for the first time in
flies that mitochondrial permeabilization not only occurs during apoptosis, but also
results in the release of a bona fide pro-apoptotic protein.
DIAP1, in addition to being regulated by dOmi, is also regulated by RING-
dependent autoubiquitination and by the N-end rule degradation (NERD) pathway.
Despite decreasing the cellular levels of DIAP1, the NERD pathway enhances its anti-
apoptotic function through an unknown mechanism(s).  Herein, we show for the first time
that the NERD pathway facilitates trans-ubiquitination and degradation of IAP antagonist
bound to DIAP1.  Indeed, Grim is trans-ubiquitinated in an Ubr1-dependent manner and
requires its interaction specifically with the BIR1 domain of DIAP1. These results
demonstrate that similar to RING domain-dependent ubiquitination, the NERD pathway
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Apoptosis or programmed cell death is critical for various aspects of development
including the removal of structures with transient functions, tissue sculpting and
morphogenesis (Vaux and Korsmeyer, 1999).  In adult multi-cellular organisms, it plays
a pivotal role not only in maintaining tissue homeostasis but also in the removal of
damaged cells and immune cells that have the potential to harm the organism (Opferman
and Korsmeyer, 2003).  Cells undergoing apoptosis exhibit morphological characteristics
such as cell shrinkage, plasma membrane blebbing, chromatin condensation, nuclear
membrane breakdown, and formation of small vesicles known as apoptotic bodies.
Subsequently, phagocytes rapidly engulf these apoptotic bodies thus avoiding a potential
inflammatory response (Kerr et al., 1972).  Necrosis, on the other hand, is a form of cell
death caused by accidental injury and is distinguished by morphological features like
cytoplasmic swelling, disruption of various organelles, and loss of membrane integrity.
In contrast to apoptosis, necrotic cell death initiates an inflammatory response due to the
rupturing of the cell and subsequent release of the cytoplasmic contents (Kerr et al.,
1972).
Elegant studies by Horvitz, Brenner, and Sulston in C. elegans have led to the
characterization of the molecular mechanism of apoptosis.  During hermaphrodite
development in C. elegans, 131 of the 1090 cells generated die by programmed cell death
(Sulston et al., 1983).  Genetic screens have identified four important loci that perturb
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this programmed cell death mechanism: ced-3 (ced for cell-death abnormal), ced-4, ced-
9, and egl-1 (egl for egg-laying defective)(Conradt and Horvitz, 1998; Ellis and Horvitz,
1986; Hengartner et al., 1992; Yuan and Horvitz, 1992) (Illustration 1.1).  The ced-3
locus encodes a pro-apoptotic cysteine protease, the chief executioner of apoptosis, which
exists as a zymogen in healthy cells (Xue et al., 1996; Yuan et al., 1993).  The ced-4
locus encodes an adaptor protein that is required for activation of CED-3.  The homotypic
interaction between CED-3 and CED-4 is required for the activation of the former
(Seshagiri and Miller, 1997).  However, in healthy cells CED-4 is sequestered due to its
interaction with an anti-apoptotic protein, CED-9 (Chinnaiyan et al., 1997; Spector et al.,
1997; Wu et al., 1997).  The cell death pathway is initiated when pro-apoptotic EGL-1
disrupts the CED-9: CED-4 interaction thereby allowing CED-4 to activate CED-3
(Conradt and Horvitz, 1998; Yan et al., 2004a).  Activation of CED-3 leads to cleavage
of several cellular substrates ultimately leading to apoptosis (Nicholson et al.,
1995)(Illustration 1.1).  Analogous to C. elegans, mammals also have similar key
regulators thus emphasizing the evolutionarily-conserved nature of apoptosis
(Hengartner, 1996).
1.2  Programmed cell death in mammals
The apoptotic pathways in mammals can be categorized as either intrinsic or
extrinsic based on the origin of death stimuli (Jiang and Wang, 2004). The intrinsic
pathway is initiated due to a death stimuli originating within the cell such as oncogene
activation or DNA damage whereas, the extrinsic pathway is triggered upon binding of
3
Illustration 1.1 Cell death pathway in C.elegans.
The activation of CED-3, through CED-3:CED-4 is required for the execution of
apoptosis.  However, in healthy cells the CED-4 is sequestered due to its interaction with
CED-9.  Upregulation of EGL-1 in response to apoptic stimuli, leads to the disruption of
CED-4:CED-9 interaction.  This is achieved by the binding of EGL-1 to CED-9 thereby,
liberating CED-4, which subsequently activates CED-3.  Once CED-3 is active it cleaves
several cellular substrates ultimately leading to cell death.
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extracellular death ligands to cell-surface death receptors. Irrespective of the nature of the
stimulus, activation of CED-3 like cysteine proteases is required for carrying out both the
pathways (Danial and Korsmeyer, 2004; Riedl and Salvesen, 2007).
1.2.1 Caspases
Caspases, a highly conserved family of cysteine proteases, are the chief
executioners of apoptosis (Hengartner, 1996).  These proteases have an active site
cysteine and cleave their substrates after an Asp residue and hence the name caspases
(cysteine-dependent Asp-specific proteases) (Alnemri et al., 1996).  Caspases contain an
N-terminal prodomain, followed by a large subunit, and a C-terminal small subunit.
They are divided into two categories based on their hierarchy of activation: initiator
caspases (caspase-2, -8, -9, and -10) characterized by the presence of long N-terminal
prodomains, and effector caspases (caspase-3, -6, and -7) with short prodomains (Riedl
and Shi, 2004).  In response to an apoptotic stimulus, caspases that exist as zymogens are
activated either proteolytically or through conformational changes (Shi, 2006).  Initiator
caspases are activated first and they in turn activate effector caspases by cleaving them at
specific internal aspartic acid residues thus leading to a cascade of caspase activation.
Once activated, the effector caspases cleave a broad spectrum of cellular targets, which
ultimately leads to cell death (Riedl and Salvesen, 2007) (Illustration 1.2).
Generally in the intrinsic pathway, caspase activation requires mitochondrial outer
membrane permeabilization (MOMP).  MOMP is regulated by the Bcl-2 family
members, which are classified as either pro- or anti-apoptotic (Illustration 1.3).  Anti-
5
Illustration 1.2 Simplified overview of intrinsic apoptotic pathway in
mammals.
Upon the receipt of an apoptotic stimulus, pro-apoptotic Bcl-2 members cause MOMP
thereby leading to the release of pro-apoptotic factors such as cytochrome c (cyt c),
Smac/Diablo, and Omi/HtrA2.  The adaptor protein, Apaf-1, along with cyt c and dATP
forms an oligomeric complex called the apoptosome, which in turn recruits caspase-9
thereby leading to its activation.  Once the initiator caspase-9 is activated, it cleaves the
effector caspase-3, which subsequently cleaves various cellular substrates leading to
apoptosis.  Active caspases-9, -3 and -7 are further inhibited by IAPs with the help of
their BIR domains.  The IAP antagonists, Smac/Diablo and Omi/HtrA2, bind to IAPs
through their N-terminal IBMs consequently leading to caspase displacement.
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apoptotic Bcl-2 proteins such as Bcl-2, Bcl-XL, and MCL-1, which are homologous to
CED-9 of C.elegans, are characterized by the presence of four Bcl-2 homology (BH)
domains (BH1-4).  Pro-apoptotic Bcl-2 members are further divided into two categories
based on the number of BH domains: multi-domain pro-apoptotic members containing
three BH domains (BH1-3) and BH3-only members (Illustration 1.3).  Anti-apoptotic
Bcl-2 members inhibit the multi-domain pro-apoptotic Bcl-2 proteins, the critical players
required for MOMP, by binding and sequestrating them.  In response to apoptotic stimuli
the BH3-only members like Bid and Bim activate the multi-domain pro-apoptotic Bcl-2
proteins like Bax and Bak leading to MOMP.  As a consequence of MOMP several inter-
membrane space resident proteins such as cytochrome c are released into the cytosol
(Danial and Korsmeyer, 2004).  The released cytochrome c then binds to an adaptor
molecule, Apoptotic protease activating factor-1 (Apaf-1), the mammalian homolog of
CED-4 (Zou et al., 1997).  Apaf-1 comprises of an N-terminal caspase recruitment
domain (CARD), a nucleotide binding domain (NBD), and a series of C-terminal WD-40
repeats. Apaf-1, upon binding to cytochrome c through its WD-40 repeats, interacts with
ATP/dATP via its NBD (Acehan et al., 2002).  Apaf-1 bound to cytochrome c and dATP
forms a heptameric complex termed the apoptosome (Acehan et al., 2002; Cain et al.,
2000; Cain et al., 1999) (Illustration 1.2).  These interactions reveal the CARD domain of
Apaf-1, thus making it competent to bind the prodomain of caspase-9, the mammalian
homolog of CED-3 (Acehan et al., 2002; Cain et al., 2000; Cain et al., 1999; Rodriguez
and Lazebnik, 1999; Zou et al., 1997).  Procaspase-9 once recruited to the apoptosome is
activated and also undergoes self-processing in the linker region between the large and
7
Illustration 1.3 Classification of Bcl-2 family members
Bcl-2 family members are classified into anti- or -pro apoptotic family members.  Anti-
apoptotic Bcl-2 family members are characterized by the presence of four Bcl-homolgy
(BH) domains: BH1, BH2, BH3 and BH4.  Pro-apoptotic multi-domain Bcl-2 subfamily
members have BH1-3 domains, which are held in check by interactions with anti-
apoptotic Bcl-2 family members.  Upon receiving apoptotic stimulus, multi-domain
proteins activate BH3-only subfamily members that are required for causing MOMP.
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small subunits (Srinivasula et al., 1998).  The active caspase-9 bound to apoptosome
further cleaves and activates effector caspases like caspase-3, which in turn cleaves
several intracellular substrates thus leading to apoptosis (Li et al., 1997) (Illustration 1.2).
1.2.2 Inhibitor of Apoptosis proteins (IAPs)
In mammals, the activated caspases are further regulated by a conserved IAP
family of proteins such as X-linked IAP (XIAP), cellular inhibitor of apoptosis protein-1
(cIAP-1), cIAP-2, melanoma IAP (ML-IAP)/Livin, neuronal apoptosis-inhibitory protein
(NAIP), Bruce/Apollon, and Survivin (Salvesen and Duckett, 2002).  The IAPs were first
identified in baculoviruses and are often characterized by the presence of one to three
baculoviral IAP repeat (BIR) motifs and sometimes a really interesting new gene (RING)
domain (Clem and Miller, 1994; Salvesen and Duckett, 2002).  The BIR is an ~ 70
residue zinc-binding domain which plays an important role in protein-protein
interactions.  The RING domain, which also comprises of a zinc-binding motif, plays an
important role in the ubiquitin ligase (E3) activity of the IAPs. In general, the RING
domain-containing proteins catalyze ubiquitination and thereby regulate the stability of
several proteins as well as themselves.  Therefore, the presence of a RING domain in
IAPs provides an important link between the ubiquitin signaling pathway (USP) and the
regulation of apoptosis.  Apart from the BIR and RING domains, cIAP1 and cIAP2 also
have a CARD domain whose role in apoptosis remains uncharacterized (Salvesen and
Duckett, 2002).
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One of the well-characterized IAPs in mammals, XIAP, consists of three BIR
domains (BIR1-3) and a C-terminal RING domain (Duckett et al., 1996; Uren et al.,
1996).  The BIR domains play an important role in binding to caspases thereby inhibiting
their activity.  The BIR3 domain of XIAP binds exclusively to the processed caspase-9
through the N-terminus of the small subunit thereby potently inhibiting its activity
(Huang et al., 2001; Srinivasula et al., 2001).  With respect to the effector caspases-3 and
-7, the linker region between the BIR1 and BIR2 domains of XIAP plays an important
role in binding and inhibiting the caspase activity.  The linker region binds to the active
site of the effector caspases thereby preventing access to substrates (Chai et al., 2001a;
Huang et al., 2001; Riedl et al., 2001). The E3 ubiquitin ligase activity of the XIAP
RING domain regulates apoptosis through ubiquitination of pro-apoptotic molecules such
as caspases (Morizane et al., 2005; Suzuki et al., 2001b).  The E3 ligase activity of XIAP
is also directed towards itself, thus regulating its own levels (Yang et al., 2000).
1.2.3 IAP antagonists
In cells undergoing apoptosis, the inhibition of caspases by IAPs is removed by a
group of proteins called IAP antagonists (Illustration 1.2).  The IAP antagonists have a
characteristic IAP-binding motif (IBM), which comprises of an unmodified alanine
residue at the N-terminus.  The IBM of an IAP antagonist is required for its interaction
with the BIR domain of the IAPs.  Either removal of the IBM or mutation of the N-
terminal residues to glycines completely abolishes the binding of IAP antagonists to the
BIR domains in IAPs.  IAP antagonists inhibit the function of IAPs by either displacing
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already bound caspases or by preventing BIR:caspase interactions (Salvesen and Duckett,
2002; Vaux and Silke, 2003).
The IAP antagonists characterized so far in mammals are mitochondrial inter-
membrane space resident proteins.  Despite their localization to mitochondria,
mammalian IAP antagonists are nuclear encoded genes.  After translation the precursor
proteins are targeted to the mitochondria via a classical mitochondrial-targeting signal
(MTS) present at their N-termini.  In mitochondria, the MTSs are removed to generate
mature proteins with IBMs at the new N-termini.  Upon MOMP, these proteins are
released into the cytosol where they neutralize the inhibitory function of IAPs (Vaux and
Silke, 2003).  Two of the extensively studied mammalian IAP antagonists include, Smac
(second mitochondria-derived activator of caspase)/Diablo (direct IAP binding protein
with low pI) (Du et al., 2000; Verhagen et al., 2000) and Omi/HtrA2 (High temperature
requirement A2) (Hegde et al., 2002; Martins et al., 2002; Suzuki et al., 2001a; Verhagen
et al., 2002).
1.2.3.1 Smac/Diablo
Smac/Diablo, in its mature form (Δ55-Smac), inhibits the function of XIAP
primarily through its N-terminal IBM, which comprises of the residues Ala-Val-Pro-Ile
(Du et al., 2000; Verhagen et al., 2000).  The N-terminal Ala of the IBM binds into a
hydrophobic pocket in the BIR2 and BIR3 domains of XIAP (Liu et al., 2000; Srinivasula
et al., 2000).  As described earlier XIAP can inhibit both caspase-9 and caspase-3 through
its interactions with the BIR domains (Salvesen and Duckett, 2002).  Smac/Diablo,
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through its IBM, antagonizes XIAP by displacing the bound caspases.  The N-terminus of
the caspase-9 small subunit and the IBM of Smac/Diablo compete for the hydrophobic
pocket in the BIR3 domain, thereby decreasing the ability of XIAP to bind and inhibit
caspase-9 (Wu et al., 2000).  Similarly, XIAP inhibition of caspase-3 is also neutralized
by the interaction of Smac/Diablo to the BIR2 domain (Chai et al., 2000; Scott et al.,
2005).  Smac/Diablo in turn can also be regulated by XIAP.  In vitro studies have
demonstrated that XIAP can inhibit the function of Smac/Diablo by RING-dependent
ubiquitination thereby promoting its degradation in a proteasome-dependent manner
(MacFarlane et al., 2002; Morizane et al., 2005).
1.2.3.2 Omi/HtrA2
Omi/HtrA2 belongs to the HtrA family of serine proteases that are well conserved
from bacteria to humans (Clausen et al., 2002). Omi/HtrA2 has an N-terminal MTS, a
transmembrane domain, protease domain, and a C-terminal PDZ domain.  The N-
terminal MTS targets Omi/HtrA2 to mitochondria, where cleavage after the trans-
membrane domain releases mature Omi/HtrA2 (Δ133 Omi) into the inter-membrane
space with an N-terminal IBM, Ala-Val-Pro-Ser (Hegde et al., 2002; Martins et al., 2002;
Suzuki et al., 2001a; Verhagen et al., 2002). The protease domain has an active site,
which is comprised of a catalytic triad: Ser-306, His-198, and Asp-228.  Mutating the
critical amino acids of the catalytic triad abolishes the protease activity of the enzyme.
Structural data suggests that the C-terminal PDZ acts as a lid over the active site thus
regulating the protease activity by restricting its access to substrates (Li et al., 2002).  In
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agreement with this data, removal of the PDZ domain enhances the activity of the
enzyme (Jones et al., 2003; Li et al., 2002). As the PDZ domain acts as a lid over the
active site, it has also been suggested that binding of certain activating peptides (or
proteins) to the PDZ domain could cause a conformational change within the tertiary
structure and allow access to the active site (Martins et al., 2003).  Mature Omi/HtrA2
exists as a homo-trimeric protein with Phe-149 critical for oligomerization.  It has been
demonstrated that trimerization also regulates protease activity by orienting the PDZ
domains into a conformation that allows for easy access of substrates to the active site of
the enzyme (Li et al., 2002).
During apoptosis, Omi/HtrA2 is released into the cytosol as a consequence of
MOMP.  Similar to Smac/Diablo, Omi/HtrA2 then relieves the inhibition of IAPs on
caspases by binding to the BIR domains of XIAP (Hegde et al., 2002; Martins et al.,
2002; Suzuki et al., 2001a; Verhagen et al., 2002).  Omi/HtrA2 also causes caspase-
dependent cell death by cleaving IAPs through its serine protease activity (Srinivasula et
al., 2003; Yang et al., 2003).  Disruption of the protease activity by mutating the active
site serine dramatically decreases the ability of Omi/HtrA2 to potentiate cell death,
underscoring the importance of its serine protease activity.  Addition of the broad-
spectrum caspase inhibitor, zVAD-fmk (N-benzyloxycarbonyl-Val-Ala-Asp (Ome)-
fluoromethylketone), does not completely inhibit the cell death caused by Omi/HtrA2.
This suggests that Omi/HtrA2 can also cause cell death in a caspase-independent manner,
presumably by cleaving various extra-mitochondrial substrates (Hegde et al., 2002;
Suzuki et al., 2001a; Verhagen et al., 2002).
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Omi/HtrA2 has also been implicated in neurodegeneration.  The mutant mnd2
(motor neuron degeneration 2) mouse is characterized by muscle wasting,
neurodegeneration, and involution of spleen and thymus. This mouse has a missense
mutation (Ser at position 276 mutated to Ala) in Omi/HtrA2, which results in a dramatic
decrease in its protease activity.  Although the aforementioned mutation does not affect
the catalytic triad it has been suggested that it disrupts the regulatory function of the PDZ
domain by holding it in a locked position (Jones et al., 2003).  In agreement with this
hypothesis, removal of the PDZ domain on this mutant background enhances the activity
of the enzyme.  The mitochondria from the mnd2 mice show increased sensitivity to
calcium induced permeability transition (Δψm) and mitochondrial membrane
permeabilization, thus suggesting that mitochondrial dysfunction may be the underlying
reason for neurodegeneration.  Intriguingly, MEFs (mouse embryonic fibroblasts)
isolated from mnd2 mice show increased apoptosis in response to treatment with stress-
inducing agents (Jones et al., 2003).  These data strongly suggest that Omi/HtrA2 plays
an important housekeeping role in mitochondria, but once released into the cytosol in
response to an apoptotic stimuli, it antagonizes IAPs and potentiates cell death.
Similar to mnd2 mutants, mice lacking the expression of Omi/HtrA2 also exhibit
neurodegeneration due to loss of certain striatal neurons.  These mice also exhibit
Parkinsonian symptoms such as progressive akinesia, lack of coordination, decreased
mobility, bended posture, and tremor that eventually leads to their death around 30 days
after birth.  Upon treatment with mitochondrial stress-inducing agents, MEFs isolated
from Omi/HtrA2 -/- mice show increased number of mitochondria with abnormal shape
14
and/or with distorted cristae.  Also, MEFs from Omi/HtrA2 -/- mice exhibit a decrease in
the levels of citrate synthase relative to wild-type mice suggesting a decrease in the
number of mitochondria (Martins et al., 2004).  The role of Omi/HtrA2 in mitochondrial
function is elevated upon the identification of mutations in four German Parkinson’s
disease patients.  These mutations include Ala141Ser and Gly399Ser, have been shown to
affect IAP binding properties and regulatory function of the PDZ domain, respectively
(Strauss et al., 2005).  However, the exact role of Omi/HtrA2 in mitochondrial
maintenance and therefore in neurodegeneration is not yet clear.
1.3 Key regulators of Drosophila apoptosis
Apoptosis is an evolutionarily-conserved process with many common features in
both vertebrates and invertebrates.  In Drosophila, similar to mammals, caspases are the
chief executioners of apoptosis. The seven Drosophila caspases identified so far include
Dronc (Drosophila Nedd-2-like caspase) (Dorstyn et al., 1999a), Dredd (Death-related
ced-3/Nedd2-like) (Chen et al., 1998), Strica (Doumanis et al., 2001; Vernooy et al.,
2000), DrICE (Drosophila ICE) (Fraser and Evan, 1997), DCP-1 (death caspase-1) (Song
et al., 1997), Decay (Dorstyn et al., 1999b), and Damm (Vernooy et al., 2000), with the
former three categorized as initiator caspases and the latter as effector caspases.
Dronc is one of the extensively characterized initiator caspases in Drosophila
(Illustration 1.4).  Animals lacking zygotic Dronc are defective for programmed cell
death and most arrest at an early pupal stage.  The Dronc mutants also exhibit other cell
death-defective phenotypes like the presence of supernumary cells, enlarged brain lobes,
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Illustration 1.4 An overview of apoptotic pathway in Drosophila.
The Drosophlia adaptor protein, Dark, is required for the activation of the initiator
caspase Dronc.  Once Dronc is activated it cleaves the effector caspase DrICE, which
subsequently cleaves various cellular substrates leading to apoptosis.  The caspases
Dronc and DrICE are inhibited by IAPs.  The RHG proteins bind to IAPs through their
N-terminal IBMs, subsequently leading to caspase displacement.
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and deformed imaginal discs underscoring the importance of Dronc in apoptosis (Chew et
al., 2004; Daish et al., 2004; Waldhuber et al., 2005; Xu et al., 2005). Similar to
mammalian caspase-9, Dronc also has a CARD domain and requires Dark, a homolog of
the adaptor protein Apaf-1, for its activation (Kanuka et al., 1999b; Muro et al., 2002;
Muro et al., 2004; Yan et al., 2006).  The importance of Dark in programmed cell death is
apparent by the fact that the null animals exhibit less apoptosis in the larval brain as well
as in embryos (Kanuka et al., 1999b).  Also, RNAi of Dark in Drosophila S2 cells
inhibits most of the caspase-dependent cell death suggesting the requirement of both
Dark and caspases for the execution of apoptosis (Kiessling and Green, 2006; Muro et al.,
2002; Muro et al., 2004; Zimmermann et al., 2002).
 Apart from its apoptotic function, Dronc has also been implicated in other non-
apoptotic roles such as compensatory proliferation as well as differentiation of spermatids
(Huh et al., 2004a; Huh et al., 2004b).  Similarly, Dredd, an initiator caspase
characterized by the presence of a death effector-like domain (DED) has been mainly
implicated in the activation of innate immunity system (Hultmark, 2003).  The function
of Strica, an initiator caspase with a serine- and threonine-rich prodomain, remains
uncharacterized yet (Doumanis et al., 2001).
DrICE and Dcp-1 are the two well-characterized effector caspases.  Similar to
their mammalian counterparts, they are activated upon cleavage by initiator caspases such
as Dronc (Hawkins et al., 2000; Meier et al., 2000) (Illustration 1.4).  Animals lacking
DrICE are pupal lethal and exhibit less cell death in the embryonic nervous system, pupal
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retinae, and adult wings.  Even in response to stress stimuli, the drice null mutants show
decreased cell death relative to wild-type animals (Muro et al., 2006; Xu et al., 2006).  In
contrast to animals lacking DrICE, dcp-1 null mutants develop into normal adults thus
implicating DrICE as one of the major effector caspase in Drosophila (Laundrie et al.,
2003).  However, mutants lacking both DrICE and Dcp-1 have severe phenotypes when
compared to drice null animals thus suggesting a redundant role of Dcp-1 (Muro et al.,
2006; Xu et al., 2006).  Similar to Dronc, DrICE has also been implicated in non-
apoptotic roles such as spermatid differentiation and compensatory proliferation (Muro et
al., 2006).
Analogous to mammals, caspase activity in Drosophila is tightly regulated by two
groups of proteins namely: IAPs and IAP antagonists (Illustration 1.4).  Three Drosophila
IAPs characterized so far include DIAP1 (Drosophila IAP 1) (Hay et al., 1995), DIAP2
(Duckett et al., 1996; Hay et al., 1995), and dBruce (Vernooy et al., 2000).  Of these
DIAP1, the IAP encoded by the thread (th) locus, is mainly implicated in regulating
apoptosis (Hay et al., 1995) (Illustration 1.4).  It is characterized by the presence of two
BIR domains (BIR1-2) and a C-terminal RING domain (Illustration 1.4A).  The C-
terminal RING domain is essential for the E3 ubiquitin ligase activity of DIAP1 (Chai et
al., 2003a; Olson et al., 2003b).  Over expression of DIAP1 in S2 cells blocks cell death
in response to apoptotic insults like ultraviolet (UV) irradiation, cycloheximide, and
actinomycin treatment (Zimmermann et al., 2002).  Conversely, RNAi of DIAP1 in S2
cells results in spontaneous cell death (Igaki et al., 2002; Kiessling and Green, 2006;
Muro et al., 2002; Yokokura et al., 2004; Zimmermann et al., 2002).  Embryos from
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DIAP1 homozygous mutant flies show increased caspase activation and cell death, thus
underscoring the importance of DIAP1 as a negative regulator in Drosophila apoptosis
(Yoo et al., 2002).  Unlike DIAP1, DIAP2 is mainly implicated in regulating innate
immunity in spite of the presence of three N-terminal BIR domains and a C-terminal
RING domain.  In contrast to DIAP1 null mutants, which are embryonic lethal, flies
lacking DIAP2 are viable and show no increased apoptosis in response to various
apoptotic stimuli (Huh et al., 2007; Leulier et al., 2006).  Instead, DIAP2 plays an
important function in antimicrobial peptide synthesis after infection with gram-negative
bacteria (Huh et al., 2007; Leulier et al., 2006).  Another atypical fly IAP that participates
in the regulation of apoptosis is dBruce. It is distinguished from the other IAPs by the
presence of only one BIR domain, which is functionally similar to the BIR1 domain of
DIAP1, and a C-terminal ubiquitin conjugating domain, characteristic of an E2 enzyme
of ubiquitin signaling pathway, instead of a ubiquitn ligase RING motif (Vernooy et al.,
2002).
The first IAP antagonists to be identified in Drosophila include Reaper (Rpr),
Grim, and Head involution defective (Hid), also referred to as RHG proteins (White et
al., 1994) (Illustration 1.4).  These were identified in a genetic screen performed to
discover novel regulators of apoptosis during embryonic development.  The h99 deletion
mutant that lacks the loci for the RHG proteins shows no developmental apoptosis, thus
providing strong evidence for the role of these proteins in positively regulating
Drosophila programmed cell death (White et al., 1994).  As discussed earlier, well-
characterized mammalian IAP antagonists like Smac/Diablo and Omi/HtrA2 are
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mitochondrial-resident proteins and over expression of the full-length proteins sensitize
the cells to various apoptotic stimuli (Vaux and Silke, 2003).  Unlike mammalian IAP
antagonists, the RHG proteins are cytosolic and when over-expressed cause massive
apoptosis (Chen et al., 1996; Grether et al., 1995; Hay et al., 1995; White et al., 1994).
For instance, ectopic expression of the RHG proteins in the fly eye using GMR (glass-
mediated response) promoter causes a severe reduced eye phenotype (Hay et al., 1995;
White et al., 1996).  Although the h99 deletion embryos show a drastic decrease in
developmental apoptotic phenotype, the mutants lacking individual genes show very
modest defects in apoptosis in certain tissues, suggesting a cooperative role for the RHG
proteins in promoting cell death in a tissue-specific manner (Grether et al., 1995;
Peterson et al., 2002).  For instance, Drosophila mutants lacking Rpr show apoptotic
defects only in neurons and an neuroblasts and display an enlarged central nervous
system (Peterson et al., 2002).  Similarly, mutants lacking Hid show a noticeable
decrease in cell death near the head region prior to the completion of head involution and
present with extra photoreceptor cells (Grether et al., 1995).  However, the decrease in
developmental cell death in the absence of the RHG proteins is far more profound
compared to mutants lacking an individual locus.
Two more IAP antagonists, Sickle (Christich et al., 2002; Srinivasula et al., 2002;
Wing et al., 2002a) and Jafrac2 (Tenev et al., 2002), have been recently identified.
Sickle, a cytosolic IAP antagonist, shows a slight increase in apoptosis when over
expressed by itself in Drosophila S2 cells (Srinivasula et al., 2002).  However, it shows
an enhanced cell death phenotype when co-expressed with the RHG proteins (Srinivasula
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et al., 2002; Wing et al., 2002a) or upon UV irradiation suggesting a synergisitic function
(Christich et al., 2002).  All of the aforementioned IAP antagonists are characterized by
the presence of a tetrapeptide N-terminal IBM, which is presumably exposed as the result
of the removal of the initiator Met by the enzyme Met-aminopeptidase (Tenev et al.,
2002; Vucic et al., 1997). Jafrac2, unlike the other Drosophila IAP antagonists, is an
endoplasmic reticulum (ER)-resident protein (Tenev et al., 2002).  In case of Jafrac2,
proteolytic cleavage in the ER subsequent to its translocation generates a neo N-terminus
with an IBM.  Similar to mitochondrial-resident mammalian IAP antagonists, processed
Jafrac2 with an N-terminal IBM is released into cytosol upon the receipt of an ER stress
stimulus.  In agreement with its apoptotic role, cytosolic expression of the mature Jafrac2,
with intact IBM, in both S2 cells as well in the Drosophila eye induces enhanced cell
death (Tenev et al., 2002) .
1.4 Mechanisms of Drosophila apoptosis
Apoptosis is a genetically programmed and tightly regulated process.  There is a
constant interplay between the positive and negative regulators of apoptosis thus forming
a well-defined, complex regulatory network.  The fate of the cell (whether to die or
survive) is dependent upon the balance that ensues as a result of these complex
interactions.  Below is the description of the interactions that occur between the key
regulators of Drosophila apoptosis in comparison with their mammalian counterparts.
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1.4.1 Regulation of caspases by DIAP1
1.4.1.1 Mechanisms of Dronc inhibition
IAPs play an important role in apoptosis by inhibiting caspases (Salvesen and
Duckett, 2002) (Illustration 1.5B).  As mentioned earlier, the mammalian procaspase-9 is
recruited to the apoptosome, a large caspase activating platform comprised of seven
Apaf-1 proteins (Acehan et al., 2002; Rodriguez and Lazebnik, 1999).  Activation of
procaspase-9 is followed by an auto-processing event between the large and small
subunits (Srinivasula et al., 1998).  As a result of auto-processing, the IBM (Ala-Thr-Pro-
Phe) at the neo N-terminus of the small subunit of caspase 9 is exposed.  XIAP inhibits
processed caspase-9 by binding to the N-terminal IBM through its BIR3 domain
(Srinivasula et al., 2001) (Illustration 1.6).  In case of Drosophila, DIAP1 also regulates
the activity of Dronc, the fly homolog of mammalian caspase-9 (Meier et al., 2000).
However, in contrast to caspase-9, activation and autoprocessing of Dronc is not required
for its interaction with DIAP1.  Rather, DIAP1 binds to the unprocessed form of Dronc
through its BIR2 domain, thereby facilitating RING-dependent ubiquitination and
degradation (Illustration 1.5B and 1.6).  In accordance with this model, animals carrying
mutations that impair the E3 ligase activity of DIAP1 enhance the cell death caused by
Dronc over expression (Wilson et al., 2002). The region of Dronc essential for binding to
BIR2 domain of DIAP1 includes a stretch of 10 amino acids from residues 114 to123 in
the prodomain with the critical residues being Phe-118, Ile-119, Leu-121, and Asn-122
(Illustration 1.6).  A non-inhibitable form of Dronc, with the Phe-118 mutated to Asp,
shows enhanced cell death when compared to the wild-type version thus suggesting the
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Illustration 1.5 Regulation of Drosophila apoptosis by DIAP1.
(A) DIAP1 is characterized by the presence of two BIR domains (BIR1 and BIR2)
and a   C-terminal RING domain required for its E3 ligase activity.
(B) DIAP1 through its BIR2 domain inhibits Dronc by thereby causing RING-
dependent ubiquitination. DIAP1 can also inhibit the activity of processed DrICE
by binding through its BIR1 domain.
(C) The RHG proteins bind differentially to the BIR domains of DIAP1.  Hid
preferentially binds to the BIR2 domain, whereas Reaper and Grim can bind to
both the BIR1 and BIR2 domains.  The RHG proteins are regulated by
ubiquitination in a RING-dependent manner.  DIAP1 levels are also regulated by
autoubiquitination.
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importance of DIAP1 binding for its inhibition (Chai et al., 2003a) .  Despite exhibiting a
different mode of binding compared to caspase-9, Dronc occupies the same binding
groove within DIAP1 as occupied by IAP antagonists.  The nature of this interaction
thereby facilitates regulation of Dronc activity by the IBM motif of IAP antagonists (Chai
et al., 2003a).
In the case of mammalian caspase-9, intra-chain processing between large and
small subunits occurs after its recruitment to the apoptosome and is not a pre-requisite for
its activation but is necessary for XIAP-mediated inhibition (Bratton et al., 2001;
Srinivasula et al., 1998; Srinivasula et al., 2001) (Illustration 1.6).  However with regard
to Dronc, preliminary data suggest that autocatalytic processing is necessary for Dronc
activation.  Processing after Asp-352, between the large and small subunits, is presumed
to happen within the Drosophila apoptosome (Illustration 1.6).  This cleavage event
changes the conformation of Dronc from a monomeric zymogen form to an active
dimeric form (Yan et al., 2006).  The dimeric conformation allows a trans cleavage event
after the Glu-143 resulting in the removal of the prodomain.  As the critical residues
required for binding to DIAP1 are present in the prodomain, the active form of Dronc is
no longer inhibitable (Yan et al., 2006) (Illustration 1.6).  This data suggests that unlike
in mammals where autoprocessing of caspase-9 enables its inhibition by XIAP,
autoprocessing of Dronc makes it uninhibitable by DIAP1 (Srinivasula et al., 2001; Yan
et al., 2006).  Therefore, DIAP1 primarily reduces the levels of unprocessed Dronc rather
than inhibiting the active form.
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Illustration 1.6 Comparison of mammalian and Drosophila caspases.
Initiator caspases are characterized by the presence of long N-terminal pro-domains
(orange), followed by large and small subunits.  Effector caspases, on the other hand,
have very short prodomains.  The intra-chain cleavage events necessary for activation are
represented by black arrows.  Cleavage events that occur after activation either by auto-
processing or cleavage by effector caspases are denoted by gray arrows.  Red lines
represent the regions necessary for IAP-mediated inhibition of initiator caspases.  The red
circles in the large subunits represent the active sites of the enzyme.
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In the case of mammalian caspase-9, cleavage by effector caspase-3 after the Asp-
330 results in removal of the N-terminal IBM of the small subunit (Illustration 1.6).
Therefore, caspase-3 initiates a feedback amplification loop by rendering the processed
caspase-9 incapable of XIAP inhibition (Bratton et al., 2002; Srinivasula et al., 2001).  In
Drosophila, DrICE also processes Dronc after Asp-135, which separates the prodomain
from the large subunit (Chai et al., 2003a).  Therefore, cleavage of Dronc by itself or by
DrICE results in the removal of prodomain thereby transforming it into a DIAP1-
uninhibitable form and initiating a feedback amplification loop similar to that in
mammals (Chai et al., 2003a; Yan et al., 2004b) (Illustration 1.6).
1.4.1.2 Mechanisms of DrICE inhibition
Similar to mammalian XIAP, DIAP1 also inhibits the effector caspases DrICE
and Dcp-1 thereby preventing them from cleaving substrates (Kaiser et al., 1998; Wang
et al., 1999).  Prior to their cleavage by the initiator caspases, caspases-3 and -7 exist in a
dimeric catalytically-incompetent conformation. Cleavage between the large and small
subunits by initiator caspases leads to rearrangement of the subunits to form a
catalytically active enzyme (Chai et al., 2001b).  XIAP then inhibits the effector caspases
by binding to their active sites and occluding substrate entry (Chai et al., 2001a; Huang et
al., 2001; Riedl et al., 2001).  Similar to mammalian caspase-3 and -7, DrICE is also
cleaved by Dronc in between large and small subunits thereby leading to its activation
(Hawkins et al., 2000).  Apart from the intra-chain cleavage, DrICE is also cleaved after
Asp-28 presumably by autoprocessing.  This cleavage leads to the exposure of an IBM
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domain, Ala-Leu-Gly-Ser (amino acids 29-32), at the neo N-terminus of the large subunit
(Tenev et al., 2005) (Illustration 1.6).  Both these cleavage events play an important role
in the inhibiton of DrICE by DIAP1.  Present data suggests that DrICE binds to DIAP1 in
a bimodular fashion, which involves both active site as well as an IBM-like motif
generated at position 29 (Tenev et al., 2005).  But, many questions regarding the order of
events and the mechanisms that lead to DrICE inhibition are still unanswered.
One of the mechanisms that remain unclear is the requirement of DIAP cleavage
for DrICE inhibition.  Once activated DrICE cleaves DIAP1 after Asp-20 (Ditzel et al.,
2003; Yan et al., 2004b) (Illustrations 1.7 & 1.9A).  Although the cleavage of DIAP1 by
DrICE is well established, the mechanism by which this cleavage affects DrICE
inhibition is under debate.  Studies by Yan et al. (2004) suggest that the BIR1 domain of
DIAP1 is in an auto-inhibitory state prior to DrICE cleavage and therefore removal of the
first twenty amino acids is a prerequisite for DrICE inhibition (Illustration 1.7).
However, other studies suggest that binding of DrICE precedes the cleavage event
(Tenev et al., 2007; Tenev et al., 2005) (Illustration 1.7).  This argument was based on the
observation that the uncleavable mutant form of DIAP1 (Asp20Ala) is still able to bind
DrICE.  Also, the DIAP1 mutant (Cys80Gly) which is unable to interact with DrICE, can
no longer act as a substrate for DrICE (Tenev et al., 2007).  Thus, the importance of
DIAP1 cleavage for its ability to inhibit DrICE remains unclear.
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Illustration 1.7 Two proposed models depicting the mechanisms of DrICE
inhibition.
By binding through its BIR1 domain, DIAP1 inhibits the effector caspase DrICE.  DrICE
once activated cleaves DIAP1 after Asp-20.  One model (left side) suggests that the N-
terminal fragment occludes binding of active DrICE to the DIAP1-BIR1 and therefore
cleavage at position 20 is a prerequisite for efficient DrICE inhibition.  Another model




1.4.2 IAP antagonists and DIAP1
1.4.2.1 Differential regulation of DIAP1 by IAP antagonists
The three extensively studied IAP antagonists of Drosophila, Rpr, Hid, and Grim
(RHG proteins), antagonize DIAP1 by binding to its BIR domains and thereby causing
displacement of caspases (Wang et al., 1999).  Similar to mammalian IAP antagonists,
the Drosophila RHG proteins inhibit DIAP1 primarily through their N-terminal IBMs.
Although all the IAP antagonists have a conserved IBM, characterized by the presence of
an N-terminal Ala, they show differential selectivity for the BIR1 and BIR2 domains in
DIAP1 (Zachariou et al., 2003)(Illustration 1.5C).  These differences are attributable to
the binding affinities of the RHG proteins for these BIR domains.  The four amino acids
at the neo N-terminus of RHG proteins include Ala-Val-Ala-Phe, Ala-Val-Pro-Phe, and
Ala-Ile-Ala-Tyr, respectively with the major determinant of the binding affinities being
the residue at position 3 (Wu et al., 2001; Yan et al., 2004b).  In DIAP1-BIR2, residues
Leu-270 and Trp-286 are required for binding to the IBM of the IAP antagonists.  Hid,
with a Pro at position 3, makes more van der Waals contacts with Leu-270 and Trp-286,
compared to Rpr and Grim which contain an Ala at this position.  As a consequence, Hid
has six-fold higher affinity (Kd = 0.041 µM) for the BIR2 domain of DIAP1 when
compared to Grim (Kd = 0.241 µM) (Wu et al., 2001).  Within the BIR1 domain of
DIAP1, Trp-103 is critical for interacting with the RHG proteins.  However, Pro-3 in Hid
sterically clashes with Trp-103 in DIAP1-BIR1, compared to Grim, which has an Ala at
this position.  This decreases the affinity of Hid for the BIR1 domain of DIAP1 (Kds: Hid
= 0.76 µM, Grim = 0.12 µM, and Rpr = 0.27 µM) (Yan et al., 2004b).  Similarly, Jafrac2
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and Sickle have a preference for binding to the BIR2 domain relative to the BIR1 domain
(Srinivasula et al., 2002; Tenev et al., 2002).
As mentioned previously, DrICE and Dronc also show preferential binding to
BIR1 and BIR2 domains respectively (Wilson et al., 2002; Zachariou et al., 2003)
(Illustration 1.5B).  Due to variations in the disassociation constants of the RHG proteins,
their ability to relieve the inhibition of initiator and effector caspases by DIAP1 is
different.  For instance, Hid plays an important role in displacing the initiator caspase
Dronc compared to DrICE (Zachariou et al., 2003).  Similarly Jafrac2, with a preference
for DIAP1-BIR2, potentiates cell death by displacing Dronc (Tenev et al., 2002).
1.4.2.2 The RHG proteins regulate the levels of DIAP1
Apart from displacing caspases, IAP antagonists can also mediate DIAP1
degradation.  Similar to other RING domain-containing proteins, the levels of DIAP1 are
also regulated by auto-ubiquitination in a RING-dependent manner (Wilson et al., 2002;
Yoo et al., 2002).  The RHG proteins regulate DIAP1 levels by modulating the rates of
auto-ubiquitination (Ryoo et al., 2002; Yoo et al., 2002).  However, there is controversy
surrounding which of the RHG proteins contribute to increased auto-ubiquitination.
Studies by Yoo et al. (2002), suggest that Hid, but not Rpr and Grim, promote
degradation of DIAP1 in a RING-domain dependent manner.  Conversely, studies by
Ryoo et al. (2002) suggest that Rpr, but not Hid, enhances the rate of DIAP1 auto-
ubiquitination.  The reasons for this disparity remain unresolved.
30
Another key player that regulates the stability of DIAP1 is Morgue (modifier of
reaper and grim, ubiquitously expressed), an ubiquitin-conjugating enzyme variant
(UEV).  Morgue regulates cell death by two related mechanisms: firstly, by enhancing
the cell death action of Rpr, and secondly, by negatively regulating the levels of DIAP1
presumably by targeting it for ubiquitin-dependent degradation.  However, several
questions regarding the exact mechanism by which Morgue decreases DIAP1 levels and
regulates Rpr-induced cell death remain unanswered (Hays et al., 2002; Wing et al.,
2002b).
1.4.2.3 IBM-independent roles of the RHG proteins
IAP antagonists Rpr and Grim can potentiate cell death even in the absence of an
intact IBM.  One of the mechanisms involves the pro-apoptotic GH3 (Grim Helix-3)
domain (also called as RH3 or Trp-block), which includes a short stretch of amino acids
that have the propensity to form a BH3-like amphipathic α-helical domain (Claveria et
al., 2002; Olson et al., 2003a).  The GH3 domain of Grim and Rpr play an important role
in their localization to mitochondria.  Disruption of the GH3 domain not only prevents
mitochondrial localization of Rpr and Grim but also decreases their ability to induce cell
death in Drosophila S2 cells (Claveria et al., 2002; Olson et al., 2003a).  Also, over
expression of Grim lacking the GH3 domain in the fly eye under the GMR-promoter
shows a decrease in the eye ablation phenotype relative to the wild-type (Claveria et al.,
2002).  Recent data suggest that the GH3 domain plays an important role in caspase-
dependent mitochondrial permeabilization, thus providing a link between the GH3
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domain and cell death (Abdelwahid et al., 2007).  However, the exact mechanism by
which the GH3 domain promotes mitochondrial permeabilization is still unknown.
The IAP antagonist Rpr also regulates IAP levels by promoting global
translational repression.  Translational repression by Rpr occurs in an IBM-independent
manner and also does not require the IAP’s E3 ligase activity (Holley et al., 2002).  Rpr
directly binds to the 40S ribosomal subunit and inhibits cap-dependent, but not IRES
(internal ribosomal entry site)-driven mRNA translation.  Therefore, Rpr modulates
protein synthesis by inhibiting the expression of cap-dependent messages (Colon-Ramos
et al., 2006).  It is still unclear if Rpr also regulates the expression of additional pro- and
anti-apoptotic proteins as a part of this global translational repression mechanism.
1.4.2.4 DIAP1 regulates the expression of RHG proteins through its E3 ligase
activity
In response to the antagonizing effects of the RHG proteins, DIAP1 retaliates by
causing their degradation.  In vitro studies demonstrate that, similar to Dronc, the RHG
proteins are also direct substrates for the E3 ubiquitin ligase activity of DIAP1
(Illustration 1.5C).  Accordingly, mutant Rpr, lacking intact lysine residues is a more
potent at inducing cell death when compared to the wild-type Rpr, suggesting that IAP
antagonists can also be regulated by the ubiquitin-proteasome system (Olson et al.,
2003b). Additionally, cell death caused by the over expression of Rpr and Grim is
enhanced in the th6B or th81.03 allelic background.  These mutations disrupt the secondary
structure of DIAP1’s RING domain (Lisi et al., 2000) and suggest that the RING domain
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can play an important role in the regulation of caspases and IAP antagonists. However,
the cell death caused by Hid is suppressed on the th6B or th81.03 allelic background,
suggesting a different mode of regulation (Lisi et al., 2000).  One of the possible
explanations for this result is that Hid rather than acting as a good substrate for DIAP1
may instead enhance the autoubiquitination of DIAP1 (Yoo et al., 2002).
1.4.3 Regulation of DIAP1 by caspases
1.4.3.1 Cleavage of DIAP1 by Dronc
 Both initiator and effector caspases play an important role in DIAP1 regulation.
The active initiator caspase Dronc cleaves DIAP1 after Glu-205 which divides DIAP1
into two fragments containing either the BIR1 domain or BIR2-RING domains (Muro et
al., 2005; Yan et al., 2004b) (Illustration 1.8A).  Both cleaved and uncleaved forms of
DIAP1 can bind to the zymogen form of Dronc, but a DIAP1 mutant lacking the cleavage
site (Glu205Ala) looses its ability to bind to active form of Dronc.  This result suggests
that the cleaved form of DIAP1 inhibits Dronc more effectively than the uncleaved form.
Moreover, the DIAP1 mutant that cannot be cleaved by Dronc is less anti-apoptotic
relative to its wild-type version (Muro et al., 2005).
1.4.3.2 DrICE cleavage promotes N-end rule-dependent degradation of DIAP1
As mentioned earlier, DrICE also cleaves DIAP1 after Asp-20 thereby creating a
neo N-terminus containing Asn as the starting residue (Illustrations 1.8A and B).  This
cleavage decreases the stability of DIAP1 due to its degradation by the N-end rule
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pathway (Ditzel et al., 2003).  The N-end rule degradation (NERD) pathway involves
ubiquitin mediated, proteasome-dependent degradation of proteins based on the identity
of the amino acid residue present at the N-terminus (Varshavsky, 2003).  In S. cerevisiae,
the model system in which the NERD pathway was first characterized, the N-terminal
amino acids that are classified as “stable” include Cys, Ala, Ser, Thr, Gly, Val, and Met,
whereas the remaining amino acids are classified as destabilizing residues.  All nascent
proteins contain an N-terminal stable Met residue, which is removed by Met-
aminopeptidases provided that the second amino acid is a stable residue.  When the
second amino acid is a destabilizing residue, the Met-aminopeptidases do not act on the
first Met.  Therefore, in order for a protein to be an N-end rule substrate (N-degron), the
pre-N-degron has to be cleaved so that it exposes an N-terminal destabilizing residue
(Illustration 1.9).  However, all the proteins with an N-terminal destabilizing residue are
not identified by the E3 ubiquitin ligase (N-recognin) that binds to N-end rule substrates
(Varshavsky, 1996).  The amino acids that can directly bind to the N-recognin are called
primary destabilizing residues, which are in turn divided into two categories, Type 1 and
Type 2.  Type 1 destabilizing residues include basic amino acids Arg, Lys, or His and the
type 2 residues include hydrophobic amino acids Phe, Leu, Trp, Ile, and Tyr.  All the
remaining destabilizing residues, which cannot be directly bound to the N-recognin, are
classified as either secondary or tertiary destabilizing residues.  Proteins with the tertiary
destabilizing residues such as Asn and Gln, are acted upon by the enzyme N-terminal-
amidohydrolase (NTAN1) and subsequently converted to secondary destabilizing
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Illustration 1.8 Regulation of DIAP1 by caspases.
(A) A schematic representing the cleavage sites of Dronc (Asp-205) and DrICE (Asp-
20) in DIAP1.
(B) A model representing the degradation of DIAP1 by the NERD pathway.  As a
consequence of DrICE cleavage, a tertiary destabilizing residue (Asn) is
generated at the neo N-terminus of DIAP1.  By sequential action of NTAN1 and
Ate1, the N-terminal Asn is attached to a primary destabilizing residue, Arg.  The
E3 ligase implicated in the NERD pathway, Ubr1 (N-recognin), recognizes the
Arg and subsequently leads to the degradation of DIAP1.
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residues Asp and Glu respectively (Illustration 1.9).  The N-terminal secondary
destabilizing residues (Asp and Glu) are further conjugated to an Arg by an enzyme Arg-
tRNA protein transferase (Ate1) thus converting it into a primary destabilizing residue.
Once the protein becomes an N-degron with an N-terminal primary destabilizing residue,
an internal lysine if present is recognized by the N-recognin and further subjected to
polyubiquitination (Illustration 1.9).  In S. cerevisiae, an E3 ligase known as Ubr1, in
conjugation with the ubiquitin-conjugating (E2) enzyme, Ubc2p (RAD6), catalyze the
addition of ubiquitin to the internal lysine residue of the N-degron, thus promoting its
proteasome-dependent degradation (Varshavsky, 1996; Varshavsky, 2003).  The
classification of amino acids into primary, secondary, or tertiary destabilizing residues
varies from each organism.  For instance, unlike in S.cerevisiae, Cys is considered as a
tertiary destabilizing residue in mammals, and it is converted to secondary and primary
destabilizing residue by a series of oxidation and arginylation reactions respectively.  The
NERD pathway has been shown to play an important role in peptide import and
chromosome stability in yeast and for cardiovascular development in mammals
(Varshavsky, 2003).
In the case of DIAP1, DrICE cleavage of the full-length DIAP1 (pre-N-degron)
exposes an N-terminal tertiary destabilizing Asn residue.  Sequential action of Ate1 and
NTAN1 enzymes is required to make DIAP1 into an N-degron, which is presumably
degraded in an Ubr1-dependent manner (Illustration 1.8).  In Drosophila S2 cells, RNAi
of Ate1 and NTAN1 increases the stability of the cleaved form of DIAP1, indicating a
requirement of NERD pathway for degradation.  Intriguingly, the decrease in stability of
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Illustration 1.9 A simplified overview of the NERD pathway.
The NERD pathway involves degradation of proteins based on the identity of the N-
terminal amino acid (stable or unstable residues).  In general, proteins are not synthesized
with a N-terminal destabilizing residue.  However, a cleavage process exposes the
destabilizing residues, which can be further classified as primary, secondary, or tertiary.
If the N-terminus of the protein is either a tertiary or secondary destabilizing residue, it is
modified by the action of the enzymes NTAN1 and Ate1 and thereby converted to a
primary destabilizing residue.  Once the N-terminus has a primary destabilizing residue
(N-degron), it is recognized by the E3 ligase (N-recognin) and is degraded in a
proteasome-dependent manner.
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the cleaved form of DIAP1 by N-end rule pathway is associated with an increase in the
anti-apoptotic ability of DIAP1.  Expression of the N-degron form of DIAP1 in S2 cells
offers more protection compared with the wild-type DIAP1 (or a stable form), especially
against Rpr-induced cell death (Ditzel et al., 2003).  These data suggests that the
degradation of DIAP1 through the N-end rule pathway is required for its anti-apoptotic
function, possibly by aiding in decreasing the activity of pro-apoptotic proteins.  In
addition, the NERD pathway has differential effects on Hid and Rpr-induced cell death.
Mutations in the enzymes NTAN1 and Ate1 that disrupt the N-end rule pathway act as
enhancers and suppressors of Rpr and Hid-induced cell death, respectively (Ditzel et al.,
2003).  However, the mechanisms that contribute to the differential effects of NERD-
dependent DIAP1 degradation on Rpr and Hid-induced apoptosis are not completely
understood and it is possible that mutations in NTAN1 and ATE1 may effect other
modifiers of Rpr and Hid besides DIAP1.
1.4.4 Role of mitochondria in Drosophila apoptosis
Although the key players of apoptosis are conserved between Drosophila and
mammals, controversy exists regarding the role of mitochondria in fly apoptosis,
especially with respect to the activation of initiator caspases (Kornbluth and White,
2005).  As mentioned previously, Dark is required for Dronc activation (Rodriguez et al.,
2002; Zimmermann et al., 2002).  Analogous to its mammalian counterpart, Dark has a
CARD domain, required for homotypic interactions, a NBD and a series of WD-40
repeats that are capable of interacting with cytochrome c (Dorstyn et al., 2002; Kanuka et
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al., 1999b).  Despite the structural similarity, it has been argued that the activation of
caspases within the Drosophila apoptosome does not require cytochrome c.  Some of the
evidence that points to the lack of mitochondria involvement in Drosophila apoptosis
includes the absence of MOMP prior to initiator caspase activation (Zimmermann et al.,
2002).  Also, the addition of exogenous or recombinant cytochrome c to Drosophila S2
cell extracts does not lead to robust caspase activation as seen in the case of mammalian
extracts (Dorstyn et al., 2004; Means et al., 2006).  Similarly, RNAi of the two forms of
cytochrome c, cyt-c-p and cyt-c-d, in Drosophila S2 cells does not inhibit apoptosis
(Dorstyn et al., 2004).  This controversy is further strengthened by the recent structural
data of the Drosophila apoptosome.  Unlike its mammalian counterpart, the Drosophila
apoptosome is composed of two rings of eight subunits each and does not require
cytochrome c for oligomerization (Yu et al., 2006).  This has led to a hypothesis that an
activating factor other than cytochrome c is required for apoptosome formation in flies
(Kornbluth and White, 2005).  In addition, there are reports suggesting that the
Drosophila apoptosome is constitutively active prior to MOMP.  This hypothesis is based
on the observation that down-regulation of DIAP1 causes spontaneous caspase activation,
suggesting that removal of inhibition over active caspases is sufficient to trigger
apoptosis, thus placing IAPs upstream of caspases in the apoptotic pathway (Yoo et al.,
2002; Zimmermann et al., 2002).  Also, overexpression of IAP antagonists, such as Rpr,
Hid, Grim, triggers massive apoptosis, suggesting that IAPs regulate apoptosis upstream
of caspases (Goyal et al., 2000; Lisi et al., 2000).  This is in contrast to the mammalian
pathway, where the activation of caspases is upstream to IAP regulation (Salvesen and
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Duckett, 2002).  In addition, it is argued that all of the Drosophila IAP antagonists, with
the exception of Jafrac2, are cytosolic, again undermining the role of mitochondria in
Drosophila apoptosis (Hay and Guo, 2006).
However, a body of work suggests that mitochondria play an important role in
Drosophila apoptosis.  One of the cytochrome c genes expressed exclusively in the male
germ line, cyt-c-d, has been implicated in spermatid individualization process (Arama et
al., 2003; Arama et al., 2006).  Similar to the mammalian apoptosis, this process requires
caspase activation and is also regulated by the IAPs.  Animals lacking cyt-c-d are
defective in DrICE activation, implying a role of cytochrome c in caspase activation.
This work also suggests that Dronc and Dark may localize near the mitochondria thus
gaining access to cytochrome c without the requirement of complete release (Arama et
al., 2003).  In addition, Rpr and Grim localize to mitochondria through their GH3
domains and have been suggested to play an important role in mitochondrial
permeabilization (Abdelwahid et al., 2007).  Based on these observations it can be
inferred that the RHG proteins may play an important role in apoptosis, not only by
antagonizing IAPs but also by causing mitochondrial permeabilization.  Whether this
leads to release of pro-apoptotic factors from mitochondria, however, remains unclear.
In addition to the above controversies, lack of understanding of the exact role of
Drosophila Bcl-2 family members in the regulation of mitochondrial MOMP further
complicates the debate.  As mentioned previously, mammalian Bcl-2 family members
have been implicated in apoptosis due to their role in modulating MOMP (Danial and
Korsmeyer, 2004).  Similar to mammals, Drosophila pro- and anti-apoptotic Bcl-2
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homologs, Debcl (Death executioner for Bcl-2 homolog) and Buffy, respectively, have
been implicated in cell death mechanisms (Brachmann et al., 2000; Colussi et al., 2000;
Igaki et al., 2000; Quinn et al., 2003).  Debcl, a Drosophila member of the muti-domain
pro-apoptotic Bax sub family, enhances apoptosis when over expressed in embryo and
larvae (Igaki et al., 2000).  Similarly, transgenic expression of Debcl in the eye produces
a rough eye phenotype, suggesting a perturbation in the cell death mechanism
(Brachmann et al., 2000).  When co-expressed with P35, a caspase inhibitor, there is only
a partial reduction in the rough eye phenotype caused by Debcl, implying its involvement
in both caspase-dependent and -independent cell death mechanisms (Colussi et al., 2000).
The anti-apoptotic Bcl-2 family member, Buffy, decreases the cell death caused by Debcl
(Quinn et al., 2003).  Although the BH4 domain, characteristic of antipoptotic Bcl-2
family members, is absent in Buffy, it is replaced by two alpha helical domains and is
required for prevention of cell death (Quinn et al., 2003).  In agreement with its anti-
apoptotic nature, RNAi of Buffy in embryos increases cell death (Quinn et al., 2003).
Despite the conserved role of Drosophila Bcl-2 family members in apoptosis, their role in
MOMP is not characterized yet.  A clear understanding of the role of Debcl and Buffy in
the regulation of MOMP, will help in further clarifying the role of mitochondria in
Drosophila apoptosis.
1.5 Significance of studying apoptosis
Deregulation of apoptosis has been implicated in several pathologies like cancer,
neurodegenerative disorders, AIDS, autoimmune disease, and viral infections
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(Thompson, 1995).  Several kinds of cancers are associated with mutations in genes that
regulate cell death pathways.  Mutations in these genes are associated with increased
resistance to apoptosis, thereby participating in the conversion of normal cells into cancer
cells.  In addition to tumorigenesis, these cancerous cells are also refractory to apoptotic
stimuli and exhibit resistance to conventional chemotherapeutic drugs and irradiation.
For instance, mutations in the tumor suppressor gene p53 have been linked to several
kinds of cancer.  p53 acts as a tumor suppressor gene by upregulating the expression of
several pro-apoptotic genes in response to genotoxic stress. Some of the genes that are
under the transcriptional control of p53 include pro-apoptotic Bcl-2 family members
(bax, bid, and puma), apaf-1, and caspase-9, which play an important role in promoting
apoptosis.  Therefore, a number of mutations in the p53 gene lead to disruption of
apoptosis and hence cancer (Fadeel and Orrenius, 2005).
Several cancers are characterized either by increased or decreased expression of
anti-and proapoptotic proteins, respectively.  For instance, Livin (ML-IAP) expression is
detected in tumor cells and fetal tissues but not adult tissues (Vucic et al., 2000).
Increased levels of XIAP and cIAP1 have been associated with bad prognosis for acute
myelogenous leukaemia and prostate cancer, respectively (Krajewska et al., 2003; Tamm
et al., 2004).  Increased expression of the Bcl-2 protein has been implicated in non-
Hodgkin’s lymphomas (Weiss et al., 1987).  In case of metastatic melanomas, Apaf-1
expression is lost due to methylation, thereby leading to defects in the execution of
apoptosis (Soengas et al., 2001).  Furthermore, mutations that inactivate the pro-apoptotic
BAX gene have been implicated in solid tumors and hematopoietic malignancies
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(Brimmell et al., 1998).  Therefore, additional insights into the roles of apoptosis in
several types of cancers are beneficial not only for identifying therapeutic targets but also
in developing prognostic markers (Fadeel and Orrenius, 2005).
Apoptosis plays a critical role in the development of the nervous system (Mattson,
2000).  Many neurons that do not receive survival signals via neurotrophic factors die by
apoptosis.  Consistent with this role, mice deficient in caspase-3, caspase-9, or Apaf-1
show prominent neuronal defects.  Apart from its role in sculpting of the nervous system,
excessive apoptosis has also been implicated in neurodegenerative diseases.  For
instance, Spinal muscular atrophy, an inherited motor neuron disease, is characterized by
the loss of anti-apoptotic IAP family member, NAIP (Roy et al., 1995).  Excessive
caspase activation has also been implicated in several neurodegenerative disorders such
as Alzheimer’s disease, Huntington’s disease, and Amyotrophic lateral sclerosis
(Mattson, 2000).
Apoptosis is essential for immune homeostasis and maintenance of immune
tolerance.  Deregulation of apoptosis is associated with defective elimination of
autoreactive T or B cells, thereby resulting in tissue destruction, a characteristic of
autoimmune disorders (Lauber et al., 2004).  Apoptosis also plays an important role in
the clearance of neutrophils (Brach et al., 1992).  These short-lived cells of the immune
system that contain proteolytic enzymes, produce reactive oxygen species, and are
essential for fighting off bacterial infections.  Disruption of this apoptotic process leads to
defects in neutrophil clearance, leading to release of noxious contents into the
extracellular space, tissue injury and development of an inflammatory response (Colotta
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et al., 1992). Therefore, a better understanding of the apoptotic process could help us in
identifying targets for several human pathologies (Fadeel and Orrenius, 2005).
1.6 Significance of studying apoptosis in Drosophila
As a model system, the fly offers several advantages for studying apoptosis.  As a
genetic tool, it can be used to identify regulators and effectors of apoptosis (Hay and
Guo, 2006).  It offers the advantage of understanding the role of apoptosis during
development as well as in differentiated adult tissues (Gorski and Marra, 2002).  When
compared to other genetic model systems, such as C.elegans and yeast, Drosophila also
has the advantage of having complexity similar to humans.  This is evident from the
conservation of key regulatory molecules involved in apoptosis.  Therefore, studying cell
death mechanisms in Drosophila can further our understanding of apoptosis in humans
(Ryoo et al., 2007).  This model system allows us to identify new pathways and
regulatory mechanisms and at the same time enhances our knowledge of the evolutionary
nature of the process.
1.7 Dissertation Objectives
The primary focus of my work was to understand the apoptotic mechanisms in
Drosophila in order to gain a greater understanding of the human cell death pathways.
The first main objective of my dissertation was to understand the role of dOmi, the fly
homolog of mammalian Omi/HtrA2, in Drosophila apoptosis.  I pursed this objective to
gain a better understanding of the role of mitochondria in Drosophila apoptosis.  I have
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shown that dOmi, similar to its mammalian counterpart, has an N-terminal MTS, a
central catalytic domain and a C-terminal PDZ domain.  With the help of the N-terminal
MTS, dOmi is translocated to mitochondria where subsequent processing results in
generation of two mature forms.  The N-termini of the two mature forms (Δ79- and Δ92-
dOmi) are IBMs, which are required for their interactions with DIAP1.  By treating
Drosophila S2 cells with various apoptotic stimuli, I have demonstrated that mature
dOmi, along with cytochrome c, are released into the cytosol as a consequence of
MOMP.  Interestingly, my data suggest that MOMP (and therefore the release of dOmi
and cytochrome c) occurs through both caspase-dependent and –independent
mechanisms, depending upon the nature of the apoptotic stimulus.  I further proceeded to
characterize the role of dOmi in Drosophila apoptosis.  I approached this question using
both over expression and RNAi methodologies, the results of which suggest that dOmi
plays an important role in caspase activation.  This work provides compelling evidence
for a conserved role for mitochondria in Drosophila apoptosis.  I have also identified the
first Drosophila mitochondrial IAP antagonist and characterized the mechanisms through
which it can potentiate apoptosis.
The second part of my work focused on the role of the NERD pathway in the
regulation of DIAP1’s function.  As mentioned previously, the NERD pathway regulates
the stability of DIAP1 as a consequence of DrICE cleavage at Asp-20.  Although the
NERD pathway decreases the stability of DIAP1, it also causes a concomitant increase in
its anti-apoptotic function with respect to Rpr-induced cell death (Ditzel et al., 2003).
However, the mechanism by which the NERD pathway enhances the anti-apoptotic
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function of DIAP1 is not well understood.  I therefore hypothesized that the NERD
pathway degrades pro-apoptotic proteins in parallel to DIAP1, thereby leading to
decreased cell death.  Previous work suggests that NERD pathway has a differential
effect on Rpr- and Hid-induced cell death.  Therefore, I also hypothesized that this
variation might be attributed to the differential binding affinity of the RHG proteins to
DIAP1.  Using a S. cerevisiae model, I have demonstrated that Grim can undergo
degradation in an N-end rule-dependent manner as described in chapter 4.  This work
suggests that other pro-apoptotic proteins, which bind to BIR1 domain of DIAP1, can be
similarly targeted for degradation through an N-end rule pathway.  Indeed, this work
demonstrates for the first time that a protein can be trans-ubiquitinated when bound to an
N-degron.  As a whole, this body of work enhances our understanding of the mechanisms
that regulate apoptosis in the fly.
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Chapter 2: Methods and materials
2.1 Methods and materials for chapter 3
2.1.1 Bacterial and fly expression constructs
Full-length and truncated dOmi constructs were PCR-amplified from an EST
(AT14262; BDGP), using Pfu polymerase (Stratagene), and cloned into pRmHa3-myc
(EcoRI-BamHI), pUAS (EcoRI-XhoI), or pET21b (NdeI-XhoI; Novagen) vectors for
expression in Drosophila S2 cells, flies, and E. coli strain BL21(DE3), respectively.
Active-site (S266A), IBM, and cleavage-site mutations were introduced by site-directed
mutagenesis (QuikChange®; Stratagene).  Similarly, the fly caspases, DRONC (residues
1-139) and full-length DrICE, were PCR amplified from ESTs (LD28292 and GH24292;
BDGP) and cloned into the NdeI-XhoI and NcoI-XhoI sites of pET21b and pET28b,
respectively.  Full-length DIAP1 was generated by SOE-PCR using an EST (L49440)
and a thread construct (kindly provided by Dr. Colin S. Duckett). For generating DIAP1-
BIR1 (residues 1-205), BIR2 (residues 205-341), and BIR1-BIR2 (residues 1-341) and
site-directed mutagenesis was utilized to introduce stop codons in pGEX-4T-1-DIAP1
and BIR2-RING. DIAP1 and various truncations were then PCR-amplified and cloned
into pIE1-HA (BamHI-NotI; Novagen) or pGEX-4T-1 (EcoRI-NotI; Pharmacia) vectors
for expression in S2 cells and E. coli, respectively.
47
2.1.2 Cell culture and transfections
Drosophila S2 cells were cultured in HyQ SFX-Insect medium (Hyclone)
supplemented with 20 mM glutamax at 28°C and were passaged every 3 days at 1:10
dilution to maintain exponential growth. For transfections, 3 x 106 cells were plated per
well of a multiwell-6 plate. Transfections were performed using Cellfectin reagent
(Invitrogen) 24 hours after plating. For transfections, 2 µg of total DNA was resuspended
in 100 µl of the medium, and was then mixed with 10 µl of cellfectin resuspended in 90
µl of the medium. After 20 minutes incubation, the mixture was added to the cells along
with 2 ml of fresh medium. For preparing the lysates, S2 cells were incubated with NP-40
lysis buffer with protease inhibitors (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% NP-
40, 1 mM PMSF, 2 µg/ml of aprotinin, 2 µg/ml of leupeptin, and 2 µg/ml of pepstatin)
for 1 hour at 4°C. The cells were centrifuged at 15,000 x g for 10 minutes and the
supernatant was collected and used for further analysis.
2.1.3 Cell death assays
For cell death experiments, cells were transfected with pRmHa3-myc constructs
encoding various dOmi proteins (1.5 µg) along with pPAC-3-GFP (0.5 µg) and then split
24 h post-transfection into multiwell-12 plates.  Protein expression was then induced with
CuSO4 (0.7 mM), in the presence or absence of Z-VAD-fmk (50 µM; Biomol).  Cell
death was assessed by flow cytometry (Beckman-Coulter FC500; λex/λem = 488/525 nm)
at various time points by quantifying the percentage of intact GFP+ cells in the induced
versus uninduced cell populations (i.e. [1-(GFP+induced/GFP+uninduced)] x 100).  The
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expression levels of dOmi and the various mutants were confirmed by western blotting
with a mouse anti-myc antibody (9B11, Cell Signaling).
2.1.4 Drosophila genetics
Transgenic flies were generated by the Transgenic Fly Core Facility of the
Cutaneous Biology Research Center at Massachusetts General Hospital.  Seven lines for
UAS-Δ79-dOmi and nine lines for UAS-Δ92-dOmi were crossed to GMR-gal4 and
scored for lethality and eye phenotypes at 25°C.  To score for suppression by p35, flies of
the genotype UAS-p35/GMR-gal4; UAS-dOmi/TM6B were compared to SM1/GMR-gal4;
UAS-dOmi/TM6B.
2.1.5 Developmental expression of dOmi
RT-PCR was performed on total RNA isolated from embryos (12 h), larvae (2nd-
instar), pupae, adults, and S2 cells, using the RNeasy and One-step RT-PCR kits
(Qiagen) and the following specific primers for domi (ggctttgcgcggttcccac and
caccggatagccagtcttgtagg) and a c t i n  (tgaagatcctcaccgagcgcggcta and
gaccggactcgtcatactcctgcttg).  Protein lysates from these tissues were also utilized for
pulldown assays using excess GST-DIAP1.  Endogenous dOmi (bound to GST-DIAP1)
was then immunoblotted with a rabbit polyclonal antibody raised against recombinant
∆79-dOmiS266A.  As a loading control, lysates were also immunoblotted for actin (Santa
Cruz, I-19).
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2.1.6 RNA interference of dOmi
For dsRNA synthesis, the template was PCR amplified using primers containing
the 5’ T7 polymerase binding site (GAATTAATACGACTCACTATAGGGAGA).  The
sequence specific primers used for dOmi and control (human TNF) are
T T A C A C A G T C A T G C A G C C A A T C G G  ( d O m i  f o r w a r d  p r i m e r ) ,
GATGTCTGATCCACGTCCTCGATG (dOmi reverse primer), CCCAGGGACCT-
CTCTCTAATCAGC (control forward primer), and GCAATGATCCCAAAGTA-
GACCTGC (control reverse primer).  The PCR products were purified (GeneluteTM Gel
Extraction Kit, Sigma) and used as templates for dsRNA synthesis (MEGAscript T7
Transcription Kit, Ambion).  The dsRNA products were ethanol precipitated and
resuspended in water.  S2 cells (0.3 x 106) were pretreated with 40 nM dsRNA for 3 days
and then exposed to STS (1 µM) for 4-12 h.  Effector caspase (DrICE) DEVDase assays
were performed at several time points as described.
2.1.7 Subcellular fractionation of Drosophila embryos
Subcellular fractionation of Drosophila embryos was performed, as previously
described (Wernette and Kaguni, 1986).  Briefly, 6-hour old pre-cellularized embryos of
D.melanogaster were collected and dechorionated in 50% bleach. The dechorionated
embryos were resuspended in homogenization buffer (HB) (15 mM HEPES, pH 8.0, 5
mM KCl, 2 mM CaCl2, 0.5 mM EDTA, 0.5 mM DTT, 0.27 M sucrose, 1 mM PMSF, 2
µg/ml of aprotinin, 2 µg/ml of leupeptin, and 2 µg/ml of pepstatin) at a ratio of 4 ml/ g
wet weight of embryos. The resuspended embryos were homogenized by three strokes of
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a glass homogenizer (Wheaton).  The homogenate was passed through a 40 µm nylon cell
strainer (BD Falcon) and the retentate was homogenized in HB at a ratio of 1 ml/ g wet
weight and filtered through the cell strainer. The filtrates obtained were combined and
centrifuged at 1,000 x g for 10 minutes and the pellet was designated as nuclear fraction.
The supernatant was further centrifuged at 15,000 x g for collecting the mitochondrial
fraction. The resulting supernatant was further fractionated into pellet enriched with
endoplasmic reticulum (ER) and the supernatant consisting of cytosolic fraction by
centrifuging at 100,000 x g.  Equal amounts of the fractions were then subjected to SDS-
PAGE and immunoblotted with rabbit anti-Lamin A/C (Cell Signaling), mouse anti-
cytochrome c (Clone 7H8.2C12; BD Pharmingen), rabbit anti-BiP (a kind gift from Dr. J.
Sisson, University of Texas, Austin), and mouse anti-α-tubulin (clone TU-01;
Biovendors Laboratory Medicine) antibodies.  Endogenous dOmi was also isolated from
each subcellular fraction using a GST-DIAP1 pulldown procedure (detailed below) and
immunoblotted using a polyclonal rabbit anti-dOmi antibody.
2.1.8 Subcellular localization of dOmi by immunofluorescence
For immunofluorescence experiments, S2 cells were transfected with pRmHa3-
myc constructs for full-length dOmi, ∆79-dOmi, or ∆92-dOmi (2 µg) and then replated (1
x 106) onto polylysine-coated coverslips in a multiwell-12 plate.  dOmi-myc expression
was induced with CuSO4 (0.7 mM), and after 24 h, the cells were washed twice with
PBS, incubated with MitoTracker Red (300 nM; Molecular Probes), fixed with 4%
paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100, and further incubated
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with 3% BSA.  Each step was performed for 10 min at 25°C.  Finally, the permeabilized
cells were incubated with a mouse anti-myc monoclonal antibody (1:1000, clone 9E10;
Sigma) for 2 h at 25°C, followed by incubation with a secondary goat anti-mouse IgG
antibody, conjugated to Alexa Fluor 488 (Molecular probes) for 1 h at 25°C.  Coverslips
were mounted onto slides in Vectashield (Vector Laboratories) and visualized with a
Nikon Eclipse TE2000S fluorescence microscope.  For cytochrome c labeling, the cells
were initially stained with a mouse anti-cytochrome c antibody (clone 6H2.B4; BD
Pharmingen), followed by secondary staining with the goat anti-mouse IgG-Alexa Fluor
488 antibody.
2.1.9 Mitochondrial release of cytochrome c and dOmi
S2 cells (4 x 106) were exposed to STS (1 µM) or UVB irradiation (5 min on a
UV illuminator), washed with PBS, and resuspended in 100 µL of digitonin lysis buffer
(75 mM KCl, 1 mM NaH2PO4, 8 mM Na2HPO4, 250 mM sucrose, 50 µg/mL of digitonin)
for 10 min on ice.  Cytosolic fractions were then collected by centrifugation (15,000 x g;
10 min) and immunoblotted with a mouse anti-cytochrome c antibody (clone 6H2.B4,
Pharmingen).  S2 cells were also transfected with empty vector or pRmHa3-dOmi-myc (2
µg), and exposed to CuSO4 (0.7 mM) for 24 h, in order to induce the expression of full-
length, mitochondrial-localized dOmi.  The transfected cells were then treated with or
without STS or UVB, and the resulting cytosolic fractions immunoblotted for dOmi-myc
using an anti-myc antibody (9B11, Cell Signaling).
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2.1.10 GST-DIAP1 pulldown assays
For the detection of endogenous dOmi, full-length GST-DIAP1 (500 nM) was
incubated with GSH-sepharose beads (30 µL; Amersham) in 300 µL of GST-PBS buffer
(140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 10 mM KH2PO4, pH 7.4) for 1 h at
25°C.  The DIAP1-bound beads were then washed three times and incubated further with
S2 cell lysates (100 µg in a total volume of 300 µL) for 3 h at 40C.  The beads were
washed extensively with GST-PBS buffer to remove any non-specific proteins, boiled in
2X-SDS loading buffer, and subjected to SDS-PAGE and immunoblotting, using a rabbit
polyclonal antibody (1:500).  To determine the domains in DIAP1 that were responsible
for binding to dOmi, identical experiments were carried out using various truncated GST-
DIAP1 proteins (Fig. 3.15A).
Similar experiments were also conducted to determine the residues in dOmi that
were necessary for binding to DIAP1.  Briefly, GST-DIAP1 (1 µM) was incubated with
GSH-sepharose beads (200 µL) in 5 mL of GST-PBS buffer for 1 h at 25°C.  GST-
DIAP1-bound beads were then washed and incubated with recombinant ∆79-dOmi, ∆92-
dOmi, or their corresponding IBM mutants or truncations (3.2 µM) in 5 mL of GST-PBS
buffer for 2 h at 25°C.  The beads were then washed extensively with wash buffer (25
mM Tris, pH 8.0, 150 mM NaCl, 2 mM DTT), and the bound proteins were eluted with
wash buffer containing GSH (5 mM), and subjected to SDS-PAGE.  In order to visualize
all proteins, gels were stained with Coomassie Blue.
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2.1.11 Displacement of DrICE and DRONC from DIAP1
To assess the potential of dOmi to antagonize BIR1-dependent inhibition of
DrICE, recombinant DrICE (175 nM) was first preincubated with GST-BIR1 (3.5 µM)
for 30 min at 25°C in assay buffer (20 mM HEPES, pH7.4, 100 mM NaCl, 0.05% NP40,
5 mM MgCl2).  Recombinant Δ79-dOmi, Δ92-dOmi, or their IBM truncation mutant
proteins (4.5 µM), were then added, along with recombinant human PARP (5.75 µM), in
a final volume of 30 µL.  Each sample was then incubated for 60 min at 25°C, and the
amount of PARP cleaved was visualized by SDS-PAGE/Coomassie Blue staining.
Identical experiments were also carried out using ∆79-IBM, Rpr-IBM, and control
peptides (5 µg) in separate incubations.
For DRONC displacement assays, GST-BIR2-RING (3 µM) was incubated with
GSH-sepharose beads (30 µL) in a total volume of 300 µL of GST-PBS for 1 h at 25°C.
After washing thrice with GST-PBS, the beads were incubated with excess DRONC
fragment (6 µM), in the absence or presence of increasing concentrations of dOmi
proteins (2-16 µM) or Rpr-IBM peptide (0.25-4 µM) for 1 h at 25°C.  The amount of
DRONC (1-139) displaced was visualized by SDS-PAGE/Coomassie Blue staining.
Band densities for both DRONC and GST-BIR2-RING were determined using ImageJ
software, and bound DRONC (normalized to the amount of precipitated GST-BIR2-
RING) was then plotted versus dOmi or Rpr-IBM using DeltaGraph.  EC50 values for
dOmi and Rpr-IBM were determined by nonlinear regression and subsequently applied to
the Cheng-Prusoff equation: Kd=EC50/(1+[ligand]/Kd*), in order to determine their disso-
ciation constants (Kd).  In our assays, the ligand concentration (DRONC, 6 µM) was
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known, and its dissociation constant, Kd* (DRONC, 0.8 µM), was previously determined
(Chai et al., 2003b).
2.1.12 Effector caspase (DEVDase) activity assays
Effector caspase (i.e. DrICE and DCP-1) activities were determined, as previously
described (Kanuka et al., 1999a).  Briefly, S2 cells (1 x 106) were treated with STS (1
µM) or UVB irradiation (5 min on a transilluminator) and collected at the indicated time
points.  The cells were washed twice with PBS, resuspended in lysis buffer (50 mM Tris,
pH7.5, 1 mM EDTA, 10 mM EGTA, 10 µM digitonin), and incubated at 37°C for 10
min.  Cytosolic fractions were subsequently collected by centrifugation (15,000 x g, 10
min) and incubated (37°C for 30 min) with an equal volume of assay buffer (20 mM
HEPES, pH 7.4, 100 mM NaCl, 0.05% NP40, 5 mM MgCl2), containing the fluorescent
substrate, Ac-DEVD-AMC (20 µM; Biomol).  DEVDase activities were then measured
(λex/λem = 360/450 nm) in a 96-well plate format using a Wallac Victor3 1420 Multilabel
counter.
2.1.13 Δψm measurements
S2 cells (1 x 106) treated with STS or UVB were incubated with 5,5’,6,6’-
tetrachloro-1,1’,3,3’-tetraethylbenzimidazolyl-carbocyanine iodide (5 µg/mL, JC-1;
Molecular Probes) for 10 min at 25°C.  Cells exhibiting red (λex/λem= 488/ 620 nm) or
green (λ ex/λem= 488/525 nm) fluorescence—corresponding to high or low ∆ψm,
respectively—were assayed by flow cytometry (Beckman-Coulter FC500).
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2.1.14 DNA fragmentation assay
In some experiments, apoptosis was measured by quantifying the percentage of
cells, exhibiting a sub-diploid DNA (i.e. sub-G1) peak.  Briefly, S2 cells (2 x 106) were
treated with STS or UVB, as described above.  At the indicated time points, the cells
were collected, washed, and resuspended in ice-cold PBS (500 µl).  Using intermittent
vortexing, the cells were then slowly mixed with ice-cold 70% ethanol (4 mL), and after
2 h on ice, the fixed cells were harvested, washed with PBS, and stained with propidium
iodide (40 µg/mL propidium iodide and 100 µg/mL RNase A in PBS) for 30 min at 37°C.
Stained nuclei were analyzed by flow cytometry (Beckman-Coulter FC500;
λex/λem= 488/620 nm).
2.1.15 Recombinant protein expression
All proteins were overexpressed in E. coli strain BL21(DE3), either as C-terminal
His6-tagged proteins or as GST fusion proteins.  For purification of dOmi proteins, 1 mL
of an overnight culture was transferred to 400 mL of LB broth and grown at 37°C to an
O.D.600 of ~ 0.4-0.5.  Protein expression was then induced with 0.1 mM isopropyl-1-thio-
β-D-galactoside (IPTG) for 16 h at 16°C.  Bacteria were collected by centrifugation,
resuspended in 40 mL of lysis buffer with protease inhibitors [50 mM NaH2PO4, 30 mM
NaCl, 10 mM Imidazole, 1 mM PMSF, 2 µg/mL of aprotinin, 2 µg/mL of leupeptin, 2
µg/mL of pepstatin, pH 7.0], lysed by sonication, and the lysates collected by
centrifugation at 20,000 x g for 30 min.  For DRONC (1-139) and DrICE, protein
expression was induced with 1 mM IPTG for 3 h at 37°C.  All His6-tagged proteins were
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purified on a column packed with Ni2+-nitrilotriacetic acid (Ni-NTA, Novagen) resin and
eluted using an imidazole gradient (0-250 mM).  Similarly, bacteria expressing GST
fusion proteins were resuspended in GST lysis buffer [140 mM NaCl, 2.7 mM KCl, 10
mM Na2HPO4, 10 mM KH2PO4, 1% Triton X-100, pH 7.4], and GST fusion proteins
were purified on a column packed with GST-Bind resin (Novagen).  Recombinant PARP
was a kind gift from Zhihua Tao and Prof. Hung-wen Liu (The University of Texas at
Austin).
2.1.16 dOmi protease assays
For in vitro dOmi protease assays, lysates of S2 cells transfected with pIE-HA-
DIAP1 (2 µg) were immunoprecipitated with mouse anti-HA antibody (5 µg; 262K, Cell
Signaling) bound to protein G sepharose beads (Amersham).  Alternatively, purified
GST-DIAP1 (1 mg) was labeled with D-Biotin-N-hydroxysuccinimide ester (Roche
Molecular Biochemicals), according to the manufacturers suggested protocol.  HA-
DIAP1 and biotinylated GST-DIAP1 (250 ng) were then independently incubated (2 h at
37°C) with recombinant ∆79-dOmi or ∆92-dOmi (50-200 nM) in assay buffer (25 mM
Tris, pH 8.0, 100 mM NaCl, and 1 mM dithiothreitol).  DIAP1 cleavage was analyzed by




Ubiquitination assays were performed as described earlier with certain
modifications. Briefly, peptides corresponding to IBMs of Reaper (AVAFYIPD), Δ79-
dOmi (AIIQREDL), Δ92-dOmi (ASKMTGRR), and a control peptide (MKSDFYFQ)
(GenScript corporation) at a final concentration of 1 µM were incubated with 0.5 µM of
recombinant BIR2-RING-GST for 15 minutes at room temperature. In parallel, 1 µl of 10
mg/ml lysate prepared from 6 hour old pre-cellularized embryos in EX buffer (20 mM
Tris-HCl at pH 7.5, 100 mM sodium chloride, 5 mM ATP, 2.5 mM MgCl2, 1 mM DTT
and 0.25 M Sucrose) was incubated with UR buffer (25 mM Tris-HCl at pH 7.5, 0.5 mM
DTT, 2 mM ATP and 5 mM MgCl2) for 15 minutes. Pre-incubated embryo lysate is
combined with the mixture containing peptides and BIR2-RING. Subsequently, 1 µg of
Flag-Ubiquitin (Sigma) was added to the mixture and incubated at 37°C. 15 µl of lysate
was collected at several time points and the reaction was stopped by adding SDS loading
buffer. Ubiquitination of BIR2-GST was analyzed by western blotting with goat anti-
GST antibody (Amersham) at 1:2,000 dilution. Similar experiments were also done using
1 µM recombinant dOmi proteins instead of peptides.
2.1.18 Structural modeling
The predicted tertiary structure of dOmi was obtained by threading the dOmi
sequence onto the hOmi structure (PDB code: 1LCY) using the program 3D-JIGSAW
(Bates et al., 2001).
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2.2 Methods and materials for chapter 4
2.2.1 Strains and culture media
Sacchoromyces cerevisiae strains used in this study include JD53 (MATα trp1-
Δ63 ura3-52 his3-Δ200 leu2-3, 112 lys2-801) and JD83-1A (MATα  ubr1Δ::HIS3 trp1-
Δ63 ura3-52 his3-Δ200 leu2-3, 112 lys2-801) (Suzuki and Varshavsky, 1999).  The
strains were grown either in rich (YPD) medium containing 2% peptone (Difco), 1%
yeast extract (Sigma), and 2% glucose (Sigma) or in synthetic yeast medium (SD
medium) containing 0.67% yeast nitrogen base without aminoacids (Difco) enriched with
auxotrophic nutrients (Qbiogene) and 2% sugars (galactose (USBiological), raffinose
(MP Biomedical), and glucose) as required. For induction of the PGAL1 promoter, the
cells were grown in SD-raffinose medium to the required density and pelleted and
transferred to SD-galactose medium.  For induction of PCUP1 promoter the strains were
grown in SD medium with CuSO4 added to a final concentration of 0.2 mM.
2.2.2 Plasmid construction
The ubiquitin-fusion plasmids encoding DIAP1 proteins were generated by
modifying the copper-inducible PCUP1 promoter containing pDhaUbXK1βgal construct.
Briefly, the pDhaUbXeK1βgal comprised of mouse DHFR gene fused to ubiquitin gene
bearing arginine instead of lysine at position 48 (K48R) through a 20-residue spacer
containing the hemagluttinin (HA-tag), which encodes the reference protein.  Following
the ubiquitin gene, sequence encoding an amino acid either Met or Arg (notated as X) is
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present.  The βgal gene was cloned after the X into BamHI and XhoI sites.  To generate
the DIAP1 ubiquitin fusion plasmids, the βgal gene is replaced by DNA corresponding to
either BIR1-GST or BIR1-BIR2-GST which were PCR amplified and subcloned into
BamHI and XhoI.  The BamHI site was later removed by site-directed mutagenesis.  The
constructs expressing Grim wild-type and GGAY mutant were generated by cloning the
coding sequence into BamHI and XhoI sites of pYES2 vector with GAL1 promoter
(Invitrogen).  Site-directed mutagenesis of the template pYES2-Grim was performed to
generate the mutant lacking lysine (pYES2-Grim (K136A)).
2.2.3 Yeast transformation
Yeast were transformed by using YEAST-1 transformation kit (Sigma).  Briefly,
S, cerevisiae strains were innoculated in 3 ml of YPD medium cultured at 30°C.  The
dense cultures were diluted to an initial O.D of ~ 0.2-0.4 in 100 ml of YPD medium and
were grown at 30°C until the final O.D reaches a value of ~ 1-1.2.  Cells were pelleted by
centrifugation for 5 minutes at 3,000 x g and washed with 50 ml of sterile water.  The
pelleted cells were than resuspended in 1 ml of transformation buffer.  For each
transformation, 500 ng of plasmid DNA and 100 µg of salmon testes DNA were added to
100 µl of cells resuspended in transformation buffer. The cells were vortexed and 600 µl
of plate buffer was added.  The cells were vortexed again and incubated at 30°C by
shaking for 30 minutes.  Cells were than heat shocked for 30 minutes at 42°C.  The heat
shocked cells were pelleted by spinning at maximum speed for 1 minute and washed with
500 µl of sterile water.  Cells were suspended in a final volume of 500 µl and plated on
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SD-glucose agar plates with the appropriate auxotrophic nutrients.  The plates with yeast
were incubated for 3 days at 30°C.
2.2.4 Degradation analysis of the ubiquitin-fusion proteins
To analyze the stability of various ubiquitin-fusion proteins of DIAP1, the
transformant colonies were innoculated in 2.5 ml of SD-glucose medium lacking Trp
(SD-Trp (glucose)) and cultured for 1-2 days until dense cultures were obtained.  Dense
cultures were diluted to an initial O.D ~0.1 and allowed to grow until they reach an O.D
of 0.8-1.2 (6-8 hours).  Cells were pelleted and resuspended into fresh SD-Trp (glucose)
medium with 0.2 mM CuSO4 to induce the ubiquitin-fusion proteins.  Cells were
collected at the required time points and resuspended in 2X-SDS loading buffer and
further analyzed by immunoblotting using rabbit polyclonal anti-GST (ab21070; Abcam)
and mouse monoclonal anti-HA (clone 16B12; Covance) antibodies.
2.2.5 Degradation analysis of the Grim protein
To analyze the stability of Grim in the presence of various ubiquitin-fusion
proteins of DIAP1, the co-transformants were innoculated in 2.5 ml of SD-raffinose
medium lacking Trp (SD-Trp-Ura (raffinose)) and cultured for 1-2 days until dense
cultures were obtained.  Dense cultures were diluted to an initial O.D ~0.1 and allowed to
grow until they reach an O.D of 0.8-1.2 (6-8 hours). Cells corresponding to 31.5 O.D
units were pelleted and resuspended in 12.5 ml of fresh SD-Trp-Ura (galactose) medium
and incubated for 3 hours to induce the expression of Grim protein.  Then 0.2 mM CuSO4
was added to the medium to induce the expression of ubiquitin-fusion proteins.
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Thereafter, 2.5 ml of the culture was collected at various time points as indicated and the
cells were resuspended in 150 µl of 2X-SDS loading buffer.  The cells were boiled for 15
minutes and spun at maximum speed for 1 min. The supernatants were further analyzed
by immunoblotting using mouse anti-HSV (69171, Novagen), anti-tubulin (clone TU-01;
Biovendors Laboratory Medicine), rabbit polyclonal anti-GST (ab21070; Abcam), and
mouse monoclonal anti-HA (clone 16B12; Covance) antibodies.
2.2.5 Viability assays
For determining the viability of the yeast harboring the vectors expressing Grim
as well as various DIAP1 proteins, the co-transformants were innoculated in 2.5 ml of
SD-Trp-Ura (raffinose) medium.  Cells corresponding to 0.5 O.D units were pelleted and
resuspended in 1 ml of sterile water.  Cells were 10-fold serially diluted and 10 µl of each
serial dilution was spotted on to the plates containing either glucose or galactose either
with or without CuSO4.  Plates were incubated for 2 days at 30°C and the viability of the
cells was analyzed visually.
2.2.5 Cell culture and transfections
Drosophila S2 cells were maintained and transfected as mentioned previously.
For Grim expression analysis, cells were also transfected with pRmHa3-Grim-HSV (2
µg) and then split 24 h post-transfection into multiwell-12 plates.  Protein expression was
then induced with CuSO4 (0.7 mM), in the presence or absence of Z-VAD-fmk (50 µM;
Biomol). The expression levels of Grim and endogenous DIAP1 were analyzed by
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western blotting with a mouse anti-HSV antibody (Novagen) and rabbit anti-DIAP1
antibody (a kind gift from Dr. Kristin White, Harvard medical school, MA).
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Chapter 3: Drosophila Omi, a mitochondrial-localized IAP antagonist
and proapoptotic serine protease
3.1 Introduction
Apoptosis, or programmed cell death, is an evolutionarily-conserved process that
is required for the normal development and homeostasis of most (if not all) metazoans.
Caspases are generally activated during apoptosis and are responsible for the biochemical
and morphological features commonly associated with this form of cell death (Danial and
Korsmeyer, 2004; Kornbluth and White, 2005).  Consequently, the mechanisms that
mediate the activation of caspases and/or regulate their activities are of considerable
interest (Fuentes-Prior and Salvesen, 2004).  In mammals, cellular stress often results in
MOMP, which facilitates the release of cytochrome c from the intermembrane space into
the cytosol.  Cytochrome c then binds to the adapter protein, Apaf-1, and in the presence
of dATP or ATP, stimulates oligomerization of Apaf-1 into a large ~700-1400 kDa
apoptosome complex that sequentially recruits and activates the initiator caspase-9 and
the effector caspase-3 (Cain et al., 2002).
Given the importance of MOMP for apoptosis, both proapoptotic (e.g. Bim, Bid,
Bax, and Bak) and antiapoptotic (e.g. Bcl-2, Bcl-xL, and Mcl-1) Bcl-2 family members
have evolved to tightly regulate this process (Danial and Korsmeyer, 2004).  Neverthe-
less, in the event that caspases are activated, a second layer of protection also exists,
comprised of the IAP proteins (Salvesen and Duckett, 2002).  Originally identified in
baculoviruses, where they serve to inhibit host cell death during viral replication, IAPs
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are characterized by the presence of one or more BIR domains and in some cases, a C-
terminal RING domain that functions as an E3 ubiquitin ligase.  XIAP, the prototypical
IAP in mammals, binds to and potently inhibits the activities of caspases-9 and -3 via its
BIR3 and linker-BIR2 domains, respectively, and may in turn catalyze the
ubiquitinylation and turnover of caspases via the 26S proteasome (Salvesen and Duckett,
2002).
By contrast, in flies previous studies suggest that MOMP does not occur and that
cytochrome c is not released into the cytosol in response to stress (Dorstyn et al., 2004;
Varkey et al., 1999; Zimmermann et al., 2002), despite the existence of both proapoptotic
(Debcl/dBorg-1/Drob-1/dBok) and antiapoptotic (Buffy/dBorg-2) Bcl-2 family members
(Igaki and Miura, 2004).  Moreover, the Apaf-1 homologue, Drosophila Apaf-1-related
killer (DARK/Hac-1/dApaf), reportedly does not require cytochrome c for its activation
and is constitutively active in cells, where it binds to and continuously processes the
initiator caspase DRONC (Dorstyn et al., 2004; Muro et al., 2002; Zimmermann et al.,
2002).  Other reports, however, suggest that cytochrome c can bind to DARK and that it
is required for DARK-dependent activation of caspases, at least during spermatid
individualization and developmental apoptosis in the fly eye (Arama et al., 2003; Arama
et al., 2006; Kanuka et al., 1999b; Mendes et al., 2006).  Thus, in flies the specific roles
that mitochondrial proteins play in apoptosis remain highly controversial (Means et al.,
2006).  Regardless, once formed, the DARK•DRONC apoptosome complex is held in
check by DIAP1, which binds via its BIR2 domain to the linker region separating the
prodomain and the large subunit (protease domain) of DRONC (Chai et al., 2003a; Meier
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et al., 2000).  Intriguingly, DIAP1 apparently does not directly inhibit DRONC activity,
but instead promotes its turnover in the cell through ubiquitinylation (Chai et al., 2003a;
Wilson et al., 2002).
Consistent with its central role in regulating apoptosis, mutations in DIAP1 that
diminish its interaction with caspases, consequently enhance or induce apoptosis (Goyal
et al., 2000; Hay et al., 1995; Lisi et al., 2000).  Moreover, a number of Drosophila IAP
antagonists have been discovered, including Rpr, Hid, Grim and Sickle, that are either
transcriptionally upregulated or posttranslationally modified in response to specific
developmental cues or stressful stimuli (Kornbluth and White, 2005).  Each of these IAP
antagonists possesses an N-terminal IAP binding motif (IBM) that displaces active
caspases from DIAP1 and/or induces DIAP1 autoubiquitinylation, resulting in the
induction of apoptosis (Kornbluth and White, 2005).  In sharp contrast, the mammalian
IAP antagonists, Smac/DIABLO and Omi/HtrA2, are constitutively expressed and
sequestered to the mitochondrial intermembrane space prior to stress-induced MOMP
(Du et al., 2000; Hegde et al., 2002; Martins et al., 2002; Suzuki et al., 2001a; Verhagen
et al., 2000; Verhagen et al., 2002).  Thus, it could be reasonably argued that MOMP may
not be required for apoptosis in flies, because their IAP antagonists are not sequestered to
mitochondria.
Recent studies however indicate that Rpr and Grim contain a second conserved
motif, referred to as the Trp-block or GH3 domain, which mediates their relocalization to
mitochondria and is required for efficient cell killing (Claveria et al., 2002; Olson et al.,
2003b; Wing et al., 2001).  Moreover, there is precedence for the sequestration of IAP
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antagonists in the fly, as Jafrac2 is initially localized to the endoplasmic reticulum (ER),
prior to its release during ER stress (Tenev et al., 2002).  Thus, we sought to further
investigate the putative role(s) of mitochondrial proteins in fly apoptosis and report here
the identification and characterization of Drosophila Omi (dOmi), the first mitochon-
drial-sequestered dual IAP antagonist and proapoptotic serine protease in flies.
3.2 Results
3.2.1 dOmi is a Drosophila Omi/HtrA2 homologue. A TBLASTN search of the
Drosophila sequence database (FlyBase) was performed using human Omi/HtrA2 (hOmi;
amino acids 1-458).  This resulted in identification of a putative omi-like homologue
(gene CG8464), which mapped to region 88C3 on chromosome arm 3R and contained
three exons spanning ~1.8 kilobases, including a 286-bp 5’-UTR, a 1270-bp coding
region, and a 92-bp 3’-UTR (Fig. 3.1A).  A full-length EST (AT14262) was subsequently
obtained, and the entire open reading frame cloned into both insect and bacterial expres-
sion plasmids.  Expression of domi confirmed that it encoded a 422 amino acid protein
with a molecular mass of ~46 kDa (see below).  Alignment of dOmi with several
members of the HtrA family revealed significant homology, particularly within the serine
protease and PDZ domains, where dOmi shares ~57% and ~45% identity with hOmi,
respectively (Fig. 3.1B).  Moreover, threading of the dOmi sequence onto the structure of
hOmi suggested significant overall structural similarity (Figs. 3.2A and B; PDB code
1LCY)(Li et al., 2002).
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Figure 3.1 Drosophila Omi is a HtrA family member.
(A) domi contains three exons spanning ~1.8 kilobases, including a 286-bp 5’-UTR
(gray), a 1270-bp coding region, and a 92-bp 3’-UTR (gray). The protein
sequence contains an N-terminal mitochondrial targeting sequence (MTS), a
serine protease domain, a hinge region, and a PDZ protein interaction domain.
(B) The coding sequence of dOmi was aligned (ClustalW) with human HtrA1,
Omi/HtrA2, HtrA3, and bacterial DegS. Red bars indicate dOmi’s two IBMs; the
red box indicates the conserved active-site serines present in all HtrA family
members.
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Figure 3.2 Drosophila and mammalian Omi are similar at tertiary structural
level.
(A) A structural model of dOmi was created by threading its primary amino acid
sequence onto the solved crystal structure of human Omi.  Structure showing the
protease domain (pink) with the active site serine (red arrow) and the PDZ
domain (gray).
(B) Overlay of dOmi (pink and gray) with human Omi (green).
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3.2.2 dOmi contains an N-terminal targeting sequence that is proteolytically
removed during mitochondrial import. hOmi, a class I intermembrane space protein,
contains a MTS that mediates its import across the outer mitochondrial membrane, as
well as its insertion into the inner mitochondrial membrane (Illustration 3.1).  Analysis of
the dOmi sequence using the PSORTII program suggested that dOmi also possessed a
putative N-terminal MTS (Fig. 3.3).  Therefore, we transiently transfected Drosophila S2
cells with a C-terminal, myc-tagged version of dOmi and examined the cells by
immunofluorescence microscopy.  As predicted, both dOmi-myc and cytochrome c
(positive control) were found exclusively in mitochondria, as indicated by their
colocalization with Mitotracker® Red (Fig. 3.5).  Immunoblotting of the dOmi-myc
transfected cells subsequently revealed that, following its import into mitochondria, dOmi
underwent N-terminal processing at two sites, resulting in the generation of two distinct
dOmi fragments (~37 and ~35 kDa) (Fig. 3.4B, lane 2).  A hydrophobicity plot of dOmi’s
N-terminus indicated the presence of a putative transmembrane domain (amino acids 63-
82)—likely utilized for insertion into the inner mitochondrial membrane (Fig. 3.3)—as
well as a second hydrophobic patch (amino acids 100-120) that was highly homologous
to the trimerization domain previously described for hOmi (Figs. 3.1B, 3.3) (Li et al.,
2002).  We therefore speculated that cleavage of dOmi might occur within the region
separating these two hydrophobic motifs.  Further analysis using the SignalP program
predicted cleavage at A79↓AIIQ, and we noted a second di-alanine motif at A92↓ASKM
(Figs. 3.3, 3.4A).  Since cleavage at these two sites would yield dOmi fragments of ~3
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Illustration 3.1 Model of dOmi import across the outer mitochondrial
membrane and processing within the intermembrane space
(IMS).
TOM/TIM23 complexes are located on the outer and inner mitochondrial membranes,
respectively.  The protease (pink), PDZ (gray), and the transmembrane (black) domains
as well as the MTS (black spiral) are represented.  dOmi is recognized by TOM/TIM23
complexes through the MTS.  After the translocation of dOmi into the inner membrane a
cleavage event occurs thereby releasing mature dOmi into IMS.
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Figure 3.3 dOmi has two putative cleavage sites after the transmembrane
domain.
A hydrophobicity plot of the N-terminus (residues 1-150) of dOmi was performed using
the TMHMM Server v. 2.0 (CBS; Denmark). The inside/outside probability
determinations indicate that residues 82-140 are located on the same side of the
intermembrane, facing the IMS.  Underlined amino acids represent the putative IBMs
obtained as a result of the cleavage event.
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and ~35 kDa, respectively, we mutated each pair of alanines to aspartic acids in an effort
to inhibit proteolytic processing.
As anticipated, mutation of Ala-92 and Ala-93 to aspartic acids almost entirely
prevented formation of the 35-kDa dOmi fragment (Fig. 3.4B; lane 4).  Similarly,
mutation of Ala-79 and Ala-80 to aspartic acids prevented formation of the 37-kDa dOmi
fragment; however, the negatively-charged aspartic acid residues disrupted the adjacent
transmembrane domain and brought about unnatural processing of dOmi at another site
(data not shown).  We therefore generated an A79W/A80W mutant, which preserved the
overall hydrophobicity of the putative cleavage site but, due to the increased size of the
tryptophan residues, completely prevented processing and formation of the 37 kDa dOmi
fragment (Fig. 3.4B; lane 3).  Interestingly, the A79W/A80W mutant also exhibited
reduced processing at the A92↓ASKM site, which suggested that dOmi was initially
processed to the 37 kDa fragment, followed by secondary processing to the 35 kDa
fragment.  dOmi did not appear to undergo autocatalytic cleavage at either site, since the
active-site serine mutant S266A failed to inhibit processing of the enzyme (data not
shown).  In any event, mutation of all four alanine residues (A79W/A80W/A92D/A93D)
resulted in essentially a noncleavable mutant of dOmi (Fig. 3.4B, lane 5).  The minor
cleavage products that were observed likely resulted from promiscuous cleavage of dOmi
by its signal peptide protease complex.  Since proteolytic processing of mitochondrial
proteins often results in the removal of their MTS residues, we next expressed the ∆79
and ∆92 mature forms of dOmi-myc in S2 cells (corresponding to the 37 and 35 kDa
fragments, respectively) and analyzed them by fluorescence microscopy.  As anticipated,
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Figure 3.4  Full-length dOmi is processed into two mature forms.
(A) A model representing the putative mature fragments obtained after the cleavage
of full-length dOmi.
(B) S2 cells were transfected with full-length wild-type dOmi-myc, or various
cleavage site mutants, for 24 h and then immunoblotted using an anti-myc
antibody.
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Figure 3.5  dOmi is a mitochondrial resident protein.
S2 cells were transiently transfected with either full-length, Δ79 or Δ92-dOmi-myc for 24
h and stained with primary anti-myc or anti-cytochrome c (positive control) antibodies,
followed by a secondary FITC-labeled anti-mouse antibody. Mitochondrial localization
was determined by staining cells with Mitotracker® Red.
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removal of these N-terminal residues from dOmi prevented its import into mitochondria,
as dOmi no longer colocalized with Mitotracker® Red and instead remained present
within the cytoplasm (Fig. 3.5).
3.2.3 Mature dOmi contains two IBMs and is developmentally-regulated in flies.
Proteolytic removal of the MTS from hOmi not only liberates the enzyme from its inner
mitochondrial membrane anchor (Illustration 3.1), but also exposes a cryptic IBM that is
required for its interaction with XIAP (Hegde et al., 2002; Martins et al., 2002; Suzuki et
al., 2001a; Verhagen et al., 2002).  Anecdotal reports have suggested that homologues of
hOmi do not contain IBMs, primarily because the AVPS motif in hOmi is not conserved
in other species, including Drosophila (Fig. 3.1B).  However, the fact that dOmi
underwent cleavage at two distinct di-alanine motifs raised the possibility that it might
contain functional IBMs.  Indeed, ∆79-dOmi contained an N-terminal AIIQ motif that
was similar to that observed for the known IAP antagonists Grim and Sickle, and ∆92-
dOmi contained an ASKM motif with the requisite N-terminal alanine, as well as a
preferred hydrophobic residue in the P4 position (Fig. 3.6A).  We therefore performed in
vitro pulldown assays using highly purified GST-DIAP1 and either recombinant ∆79-
dOmi or ∆92-dOmi.  As shown in Fig. 3.6B, DIAP1 bound each of the cleaved forms of
dOmi (lanes 3, 5, 9, and 11), but failed to do so when the corresponding IBMs (AIIQ and
ASKM) were removed (lanes 4 and 6) or when the first two amino acids were mutated to
glycines (lanes 10 and 12).  Thus, proteolytic removal of the MTS from dOmi resulted in
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the formation of two fragments, both of which possessed N-terminal IBMs capable of
binding to DIAP1.
To verify that processing of endogenous dOmi occurred within mitochondria and
resulted in the generation of IAP antagonists in flies, we prepared lysates from wild-type
embryos (12 h) and performed DIAP1 pulldown assays using various subcellular
fractions.  DIAP1 precipitates were then immunoblotted with a rabbit polyclonal antibody
raised against recombinant ∆79-dOmi.  As expected, DIAP1-bound dOmi fragments were
isolated exclusively from the mitochondrial fraction (Fig. 3.7).  We then prepared lysates
from embryos (12 h), larvae (2nd instar), pupae, and adult flies, as well as S2 cells, and
once again performed pulldown assays using GST-DIAP1.  Intriguingly, we found that
the expression of dOmi fluctuated depending upon the developmental stage of the flies.
dOmi expression levels were initially high in embryos, but declined during the larval and
pupal stages, only to rebound in the adult flies (Fig. 3.8).  The observed changes in dOmi
expression could not be accounted for by differences in total mitochondrial density, as
cytochrome c levels were increased only in the adult flies (Fig. 3.8).  We performed RT-
PCR on total RNA isolated from each tissue sample and correspondingly observed that
domi expression was slightly reduced in both larvae and pupae (Fig. 3.8).  It is currently
unclear why dOmi expression levels change during development, or if additional
posttranslational modifications (e.g. ubiquitinylation) may also enhance its turnover.
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Figure 3.6  Mature dOmi binds DIAP1 via two distinct IBMs.
(A) The IBMs in Δ79-dOmi and Δ92-dOmi were aligned with known IAP antagonists
in Drosophila (Reaper, Grim, Hid, Sickle, Jafrac2) and humans (Δ133-hOmi,
Δ55-Smac).
(B) GST-DIAP1 pulldown assays were performed using recombinant Δ79-dOmi and
Δ92-dOmi, as well as their corresponding IBM truncations (ΔAIIQ, ΔASKM) or
point mutants (GGIQ, GGKM), respectively. Each of the dOmi proteins also
contained an active-site mutation (S266A). Isolated protein complexes were
separated by SDS-PAGE, and the gels were stained with Coomassie Blue.
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Figure 3.7  Processing of dOmi occurs in the mitochondria.
Subcellular fractions were isolated from fly embryo (12 h) lysates and incubated with
GST-DIAP1. DIAP1 complexes from each fraction were then washed and
immunoblotted for endogenous dOmi, using a rabbit polyclonal antibody raised against
recombinant dOmi. Each fraction was also immunoblotted for cytochrome c, lamin C,
BiP, and α-tubulin, in order to verify the purity of the fraction.
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Figure 3.8  Expression of dOmi is developmentally regulated.
Lysates from embryos (12 h), larvae (2nd instar), pupae and adult flies were
immunoblotted for cytochrome c and endogenous dOmi (as described in Fig. 3.6). Total
RNA was also isolated at each developmental stage and subjected to RT-PCR for domi
and actin (internal control).
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3.2.4 Mature dOmi is released from mitochondria during apoptosis via caspase-
dependent and -independent mechanisms.  As previously noted, the role of
mitochondria in fly apoptosis remains highly controversial, in part because some previous
reports suggest that mitochondria do not undergo outer membrane permeabilization and
that cytochrome c is not required for activation of the DARK•DRONC apoptosome
complex (Dorstyn et al., 2004; Varkey et al., 1999; Zimmermann et al., 2002).
Therefore, in order to determine if cytochrome c was released from mitochondria during
apoptosis, we treated S2 cells with the general serine/threonine kinase inhibitor
staurosporine (STS) or exposed them to DNA-damaging UVB irradiation.  In each case,
we observed the release of cytochrome c from mitochondria (Figs. 3.9G and H), a loss in
mitochondrial membrane potential (∆ψm) (Figs. 3.9C and D), an increase in effector
caspase DEVDase activity (Figs. 3.9E and F), and DNA fragmentation (SubG1 peak)
(Figs. 3.9A and B).  Similarly, in cells transfected with full-length dOmi-myc, STS and
UVB irradiation also stimulated the release of both ∆79-dOmi and ∆92-dOmi, along with
cytochrome c (Fig. 3.10), and once in the cytosol, mature dOmi enhanced effector
caspase DEVDase activity (Fig. 3.11).  Correspondingly, in loss-of-function experiments,
depletion of dOmi by RNA interference delayed caspase activation (Fig. 3.12).
Interestingly, pretreatment of cells with the pancaspase inhibitor Z-VAD-fmk
inhibited all of the aforementioned events in UVB irradiated cells, including the release
of cytochrome c and dOmi, but failed to do so in STS treated cells (Fig. 3.9, 3.10).  Thus,
depending upon the proapoptotic stimulus, both cytochrome c and dOmi were released
from mitochondria via caspase-dependent and -independent mechanisms, the precise
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Figure 3.9 STS and UVB irradiation induce caspase-dependent and
–independent MOMP in S2 cells.
S2 cells were exposed to STS (1 µM) (A, C, E, and G) or UVB irradiation (5 min on a
UV transilluminator) (B, D, F, and H), in the presence or absence of the pancaspase
inhibitor Z-VADfmk (50 µM). Cells were subsequently examined for ΔΨm (JC-1
staining) (C and D) and DNA fragmentation (SubG1 peak) (A and B). In addition,
cytosolic fractions were prepared and immunoblotted for cytochrome c (G and H)and
assayed for effector caspase DEVDase activity (E and F).
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Figure 3.10 dOmi, similar to cytochrome c, is released into cytosol in a caspase-
dependent and –independent manner in S2 cells.
S2 cells transfected with full-length dOmi were exposed to STS (1 µM) or UVB
irradiation (5 min on a UV transilluminator).  Cells were lysed with digitonin and
cytosolic fractions were isolated by differential centrifugation.  We then examined for
mitochondrial release of cytochrome c and dOmi into the cytosol by immunoblotting.
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Figure 3.11 Overexpression of full-length dOmi sensitizes cells to STS treatment.
S2 cells were either transfected with a vector control or plasmid expressing full-length
dOmi under the control of the metallothionein promoter.  The expression of dOmi is
induced by the addition of CuSO4 (0.7 mM) to the culture medium. The cells were
exposed to STS (1 µM) 24 hours after induction with CuSO4.  Effector caspase DEVDase
activity was measured at various time points as indicated by fluorometric assay.
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Figure 3.12 Knock down of dOmi by RNAi decreases the caspase activation after
STS treatment.
(A) S2 cells (0.3 x 106) were pretreated with control or domi dsRNA (40 nM) for 3
days, exposed to STS (1 µM) for 4-12 h, and subsequently assayed for effector
caspase DEVDase activity.
(B) Levels of dOmi mRNA in control and dsRNA treated cells was measured by RT-
PCR.
(C) The effect of dsRNA on dOmi protein levels was analyzed by immunoblotting.
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details of which remain to be elucidated.  Notably, UVB irradiation selectively induces
expression of DARK in early stage embryos (Zhou and Steller, 2003).  Therefore, it is
possible that DRONC, or perhaps its downstream targets, DrICE or DCP-1, may be re-
quired for MOMP in this context.
3.2.5 Mature dOmi induces cell death in S2 cells and in the developing fly eye,
primarily through its serine protease activity.  Though dOmi was released from
mitochondria during apoptosis, it remained unclear precisely how cytoplasmic dOmi
might induce apoptosis in Drosophila cells.  We therefore expressed mature ∆79-dOmi or
∆92-dOmi in the cytoplasm of S2 cells (Fig. 3.5) and found that both forms induced
~40% cell death by 48 h (Figs. 3.13A and E, WT vs. Vec Ctrl).  Interestingly, however,
the IBM mutants ∆79-dOmiGGIQ and ∆92-dOmiGGKM triggered similar levels of cell death
compared to wild-type dOmi (Figs. 3.13A and B, WT vs. IBM Mt), despite their inability
to bind DIAP1 (Fig. 3.6B).  Moreover, mutation of dOmi’s catalytic serine reduced cell
death (Figs. 3.13A and C, WT vs. S266A), whereas removal of its regulatory PDZ
domain (which provides greater access to its active-site) significantly enhanced cell death
(Fig. 3.2A; Figs. 3.13A and D, WT vs. ∆PDZ).  Thus, dOmi’s serine protease activity
appeared to be primarily responsible for inducing cell death in S2 cells.  Pretreatment of
cells with Z-VAD-fmk partially inhibited cell death induced by the catalytically-active
forms (WT, ∆PDZ, IBM Mt) of dOmi (Figs. 3.13A, D, and B), indicating that dOmi’s
proteolytic activity could promote the activation of caspases and induce caspase-
dependent apoptosis.  However, dOmi, like its mammalian counterpart, also induced
caspase-independent cell death (Hegde et al., 2002).
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To determine if dOmi could induce cell death in the developing fly eye, we
generated transgenic flies expressing wild-type ∆79-dOmi (GMR-gal4;UAS-domi∆79wt
7B), ∆92-dOmi (GMR-gal4;UAS-domi∆92wt5A), or their catalytically-inactive S266A
mutants (GMR-gal4;UAS-dOmi∆79S266A4A and GMR-gal4;UAS-dOmi∆92S266A42A).
Interestingly, when compared to control flies, expression of ∆79-dOmi and ∆92-dOmi
resulted in phenotypes ranging from organismal lethality at pupal stages to a rough eye
(Figs. 3.14A and B).  The effects of ∆92-dOmi were consistently much stronger than
∆79-dOmi (Fig. 3.14B), but as previously observed in S2 cells, expression of the
catalytically inactive S266A dOmi mutants did not result in any phenotype (Fig. 3.14A).
In contrast to the effects of Z-VAD-fmk in S2 cells, expression of the baculoviral caspase
inhibitor p35 did not inhibit cell death induced by ∆79-dOmi or ∆92-dOmi (Fig. 3.14A;
data not shown).  GMR-driven expression of dOmi in the fly eye however occurred over
an ~4 day period throughout pupal development, whereas the effects of dOmi expression
in S2 cells were examined after 1-2 days.  Thus, dOmi could promote caspase-dependent
apoptosis via its serine protease activity, but in the long term did not require caspase
activity in order to induce cell death.
3.2.6 The IBMs in dOmi interact selectively with the BIR2 domain in DIAP1 and
displace the initiator caspase DRONC.  Rpr, Hid, Grim, Sickle and Jafrac2 all
reportedly induce apoptosis in the fly by interacting with and displacing the effector
caspase DrICE from the BIR1 domain in DIAP1 and/or the initiator caspase DRONC
from the BIR2 domain (Chai et al., 2003a; Yan et al., 2004b; Zachariou et al., 2003).
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Figure 3.13 Mature dOmi induces cell death in S2 cells.
S2 cells were cotransfected with expression plasmids for EGFP and wild-type dOmi
(Δ79-dOmi, Δ92-dOmi) (A), or various IBM mutants (Δ79-dOmiGGIQ, Δ92-dOmiGGKM) (B),
catalytically-inactive mutants (Δ79-dOmiS266A, Δ92-dOmiS266A) (C), PDZ truncation
mutants (Δ79-dOmiΔPDZ, Δ92-dOmiΔPDZ) (D), or vector control (E).  All dOmi constructs
were expressed under the control of the metallothionein promoter by adding CuSO4 (0.7
mM) to the culture medium, in the presence and absence of Z-VAD-fmk (50 µM).  Cell
death was assessed by determining the percent of GFP+ cells remaining at 24 and 48 h.
For statistical analyses, ANOVA was performed, along with a Student-Newman-Keuls
posthoc analysis (StatView software): *, significantly different from the Vec Ctrl
(p<0.05); #, significantly different from cells not treated with Z-VAD-fmk (p<0.05).
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Figure 3.14 Mature dOmi causes eye ablation phenotype when expressed in
Drosophila eye.
(A) Expression of Δ79-dOmi resulted in phenotypes ranging from early pupal
lethality in some lines to a mild, slightly rough eye in other lines (as shown:
GMR-gal4/+; UAS-Δ79-dOmi7B). Expression of Δ92-dOmi resulted in
consistently stronger phenotypes, ranging from early pupal lethality in some lines
to eyeless flies in other lines (as shown: GMR-gal4/+; Δ92-dOmi5A/+). Co-
expression of the baculoviral caspase inhibitor p35 failed to significantly inhibit
cell death induced by Δ79-dOmi or Δ92-dOmi (as shown: GMR-gal4/UAS-p35;
Δ92-dOmi5A/+), and expression of the catalytically-inactive dOmi mutants failed
to induce cell death (as shown: GMR-gal4/+; UAS-Δ79-dOmiS266A4A and
GMR-gal4/+; UAS-Δ92-dOmiS266A 42A).
(B) Transgenic lines were crossed to GMR-gal4 and scored for phenotype based on
the scale. Nine independent lines were scored for Δ92-dOmi and seven for Δ79-
dOmi, and each line was tested at least twice and produced at least 10 flies with
the same phenotype. Expression of Δ92-dOmi consistently resulted in a more
severe phenotype (p<0.02, student T test).
89
Therefore, since dOmi clearly bound to DIAP1 in an IBM-dependent manner (Fig. 3.6B),
it was surprising that this interaction alone failed to induce significant amounts of
apoptosis in S2 cells or in the developing fly eye (Figs. 3.13A and E, S266 vs. Vec Ctrl;
data not shown).  In order to resolve this dilemma, we sought to further characterize
dOmi’s interaction with DIAP1, as well as its role in promoting caspase activation.  We
began by expressing various DIAP1 truncation mutants as GST fusion proteins and
subsequently performed pulldown assays using naïve S2 cell lysates (Figs. 3.15A and B).
Importantly, the BIR2 domain in DIAP1 was found to be essential for binding both
processed forms of endogenous dOmi, whereas neither the BIR1 nor the RING domains
were required (Fig. 3.15B).
Given that dOmi failed to bind BIR1, we predicted that it would be unable to
antagonize BIR1-dependent inhibition of DrICE.  To provide definitive proof, we
incubated recombinant DrICE with its substrate PARP, either alone or in the presence of
GST-BIR1.  At its approximate IC50, GST-BIR1 inhibited DrICE-mediated cleavage of
PARP by ~50% (Figs. 3.17A and B, lanes 1-3).  As expected, this inhibition was readily
overcome by a Rpr peptide, matching its N-terminal IBM (Rpr-IBM; AVAFYIPD), but
not by a control peptide (MKSDFYFQ) (Fig. 3.17B, lanes 4 and 6).  More importantly,
however, neither recombinant ∆79-dOmi, ∆92-dOmi, nor their IBM truncation mutants
(∆AIIQ or ∆ASKM) promoted DrICE-dependent cleavage of PARP (Fig. 3.17A, lanes 4-
7).  Moreover, unlike Rpr-IBM, the IBM peptide of ∆79-dOmi (AIIQREDL) also failed
to antagonize BIR1-dependent inhibition of DrICE (Fig. 3.17B, lanes 4-5).  To determine
why dOmi failed to displace DrICE, we modeled the ∆79-IBM into the BIR1 binding
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Figure 3.15 Mature dOmi binds to the BIR2 domain in DIAP1.
(A) Schematic representing GST-DIAP1 and truncation mutants.
(B) Proteins of GST-DIAP1 and various truncation mutants were expressed in
bacteria and purified to homogeneity. The proteins (500 nM) were then captured
using GSH-sepharose beads and incubated (3 h at 4°C) with naïve S2 cell lysates
(100 µg) in a final volume of 300 µL. The bead complexes were subsequently
isolated, separated by SDS-PAGE, and immunoblotted using a rabbit anti-dOmi
polyclonal antibody.
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Figure 3.16 The IBM of Δ79-dOmi shows exhibits differential binding to the BIR1
and BIR2 domains of DIAP1.
Structural modeling representing the binding of Δ79-IBM to BIR1 (A) and BIR2 domains
(B) in DIAP1 was done by using the previously solved crystal structures of BIR1:Rpr-
IBM and BIR2:Hid-IBM.
92
Figure 3.17 Mature dOmi cannot displace BIR1 domain bound active DrICE.
(A) Recombinant DrICE (175 nM) was preincubated with or without GST-BIR1
(inhibitor; 3.5 µM) for 30 min at 25°C. Human PARP (substrate, 5.75 µM) was
then added alone, or in combination with recombinant Δ79-dOmi, Δ92-dOmi, or
the IBM truncation mutants (ΔAIIQ, ΔASKM) (4.5 µM), and further incubated
for 60 min at 25°C. All protein complexes were separated by SDS-PAGE, and
the gels stained with Coomassie Blue.
(B) DrICE displacement was also analyzed by using Δ79-IBM peptide and the
positive control, Rpr-IBM peptide (5 µg), in separate incubations.
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pocket of DIAP1, using the previously solved crystal structure for BIR1 bound to Rpr-
IBM (PDB code: 1SDZ) (Yan et al., 2004b).  As shown in Fig. 3.16A, Arg5 in dOmi
appeared to sterically clash with Glu86 in the bottom of the BIR1 pocket, thus preventing
∆79-dOmi from forming a stable complex with BIR1.
Since mature dOmi bound to the BIR2 domain in DIAP1 (Fig. 3.15B), we
predicted that dOmi might displace the initiator caspase DRONC from the BIR2 binding
pocket.  We therefore incubated GST-BIR2-RING with an N-terminal fragment of
DRONC (1-139) and observed the formation of a BIR2-RING•DRONC complex (Fig.
3.18A, lanes 1 and 10), consistent with a previous report (Chai et al., 2003a).  As
expected, addition of ∆79-dOmi or ∆92-dOmi to the incubation mixture resulted in a
concentration-dependent displacement of DRONC from the complex (Fig. 3.18A, lanes
2-5 and 11-14), with ∆79-dOmi displaying a higher affinity for BIR2-RING compared to
∆92-dOmi (Kd ~0.27 µM vs. ~1.18 µM) (Table 3.1).  By contrast, neither of the IBM
truncation mutants (∆AIIQ or ∆ASKM) bound to BIR2-RING or displaced DRONC (Fig.
3.18A, lanes 6-9 and 15-18).  In additional experiments, the Rpr-IBM peptide also
displaced DRONC from the BIR2 binding pocket (Fig. 3.18B), with an affinity similar to
that reported for the Hid-IBM (Kd ~0.036 µM vs. 0.041 µM) (Table 3.1).  Thus, in our
assays, Rpr was ~7-fold more potent than ∆79-dOmi at displacing DRONC (Table 3.1)
(Wu et al., 2001).  Nevertheless, the affinity of ∆79-dOmi for DIAP1-BIR2 was ~3-fold
higher than that reported for DRONC (Table 3.1) (Chai et al., 2003a).  Moreover, by
comparison, the affinity of ∆79-dOmi for DIAP1-BIR2 was higher than that reported for
Smac with XIAP-BIR3 (Liu et al., 2000), which is compelling given that DRONC and
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Figure 3.18 Mature dOmi displaces the BIR2 domain bound initiator caspase
DRONC.
GST-BIR2-RING (3 µM) was incubated with an N-terminal fragment of DRONC (6
µM), in the absence or presence of the Rpr-IBM peptide (0-4 µM) (B), recombinant Δ79-
dOmi, Δ92-dOmi, or their corresponding IBM mutants (ΔAIIQ, ΔASKM) (A) (2-16 µM).
The dOmi proteins also contained an active-site mutation (S266A) to ensure that dOmi’s
proteolytic activity did not interfere with the displacement of DRONC. Displacement
curves were plotted to determine the EC50 values for each of the Rpr-IBM peptide and
dOmi proteins (C and D). All protein complexes were then separated by SDS-PAGE, and
the gels were stained with Coomassie Blue.
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Table 3.1 The IBM of mature dOmi has less affinity towards BIR2 domain in
DIAP1 relative to Rpr-IBM.
The dissociation constants for specific fly and mammalian IAP antagonists and initiator
caspases with their respective IAPs were compared.  The dissociation constants of Δ79-
IBM, Δ92-IBM, and Rpr-IBM were calculated using Cheng-Prusoff equation and the
EC50 values were obtained from Fig. 3.19C and D (a).  Other Kd values were obtained
from Chai, et al. (b) and Liu, ei al. (c) and used for comparison.
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caspase-9 exhibit virtually identical binding affinities for their respective IAPs (Table
3.1).
The reasons for the selectivity of ∆79-dOmi for BIR2 over BIR1 were subse-
quently revealed through modeling studies, using the solved crystal structure of BIR2
bound to Hid-IBM (PDB code: 1JD6) (Wu et al., 2001) (Fig. 3.16B).  Indeed, the steric
clash observed between Arg-5 in ∆79-dOmi and Glu-86 in BIR1 (Fig. 3.16A) did not
exist in the BIR2 model, as Glu-86 is replaced by a glycine in the analogous position
(Gly269) (Fig. 3.16B).  Arg-5 appeared to exhibit some electro-repulsion with Arg-260
and Arg-262 in BIR2, and thus may account for the reduced affinity of ∆79-dOmi for
BIR2 compared to Rpr and Hid (Table 3.1 and Fig. 3.16B).  Collectively, the biochemical
and structural data indicate that ∆79-dOmi can selectively displace DRONC from the
BIR2 domain in DIAP1.  However, this interaction is insufficient, on its own, to induce
significant levels of cell death, perhaps because the BIR1 domain retains its ability to
inhibit the effector caspase, DrICE.  Indeed, we have previously shown in human cells
that the linker-BIR2 domain in XIAP can inhibit the effector caspase-3 and prevent cell
death, even when mutations in its BIR3 domain prevent inhibition of the initiator
caspase-9 (Bratton et al., 2002).
3.2.7 dOmi alleviates DIAP1 inhibition of caspases by proteolytically degrading
DIAP1.  Though wild-type dOmi clearly induced cell death in both S2 cells and the
developing fly eye via its serine protease activity, it remained unclear precisely how this
led to caspase activation.  hOmi proteolytically degrades certain IAPs in mammalian
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cells, including cIAP1, cIAP2 and Bruce/Apollon (Jin et al., 2003; Yang et al., 2003),
raising the possibility that dOmi might indirectly increase caspase activity, at least in
part, by degrading DIAP1.  We therefore examined the effects of dOmi on the expression
levels of DIAP1 in S2 cells.  As shown in Fig. 3.19A, DIAP1 was largely absent from
cells when coexpressed with wild-type ∆79-dOmi, ∆92-dOmi, or the IBM mutants (lanes
2, 4, 5, and 7), whereas DIAP1 was readily detected in cells coexpressing the
catalytically-inactive S266A mutants (lanes 3 and 6).  Thus, dOmi’s proteolytic activity
was responsible for mediating the loss in DIAP1, independent of its IBMs.  We next
incubated recombinant dOmi with DIAP1 (immunoprecipitated from transfected S2 cells)
and found that both ∆79-dOmi and ∆92-dOmi directly degraded DIAP1 in a concen-
tration-dependent manner (Fig. 3.19B).  However, it was difficult to visualize many of
the DIAP1 fragments, due to proteolytic removal of the HA tag.  Therefore, we repeated
our in vitro cleavage assay by incubating recombinant dOmi with GST-DIAP1 that was
first purified and then biotinylated.  Under these conditions, dOmi once again
proteolytically processed DIAP1 into numerous fragments that were readily visualized by
blotting with streptavidin-HRP (Fig. 3.19C).
As previously noted, a number of recent studies have suggested that other IAP
antagonists in the fly may stimulate DIAP1 autoubiquitinylation and target DIAP1 for
destruction by the 26S proteasome (Hays et al., 2002; Holley et al., 2002; Ryoo et al.,
2002; Wing et al., 2002b).  dOmi, on the other hand, did not appear to induce DIAP1
autoubiquitinylation, since neither ∆79-dOmiS266A nor ∆92-dOmiS266A induced a loss in
DIAP1, when coexpressed in S2 cells (Fig. 3.21A, lanes 1, 3 and 6).  Furthermore, in
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Figure 3.19 dOmi proteolytically degrades DIAP1.
(A) S2 cells were cotransfected with pIE1-HA-DIAP1, along with pRmHa3-dOmi
(Δ79-dOmi, Δ92-dOmi), catalytically inactive mutants of dOmi (Δ79-dOmiS266A,
Δ92-dOmiS266A) or IBM mutants of dOmi (Δ 79-dOmiGGIQ, Δ92-dOmiGGKM).
Following the addition of CuSO4 (0.7 mM) to induce expression of dOmi and its
mutants, whole cell lysates were immunoblotted for DIAP1and dOmi expression
levels.
(B) HA-DIAP1 was expressed in S2 cells and immunoprecipitated using an anti-HA
antibody (262K, Cell Signaling). The immunoprecipitates were then incubated
with wild-type Δ79-dOmi or Δ92-dOmi (50-200 nM) for 2 h at 37ºC and
subsequently immunoblotted for HA-DIAP1.
(C) Biotinylated GST-DIAP1 (250 ng) was incubated with recombinant Δ79-dOmi or
Δ92-dOmi (50-200 nM) for 2 h at 37ºC in a total volume of 30 µL and
subsequently immunoblotted with streptavidin-HRP.
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subsequent in vitro assays using fly embryo lysates, neither recombinant dOmi, nor the
∆79-IBM peptide, enhanced (or suppressed) the basal level of DIAP1 autoubiquitinyla-
tion (data not shown).  Thus, dOmi promoted caspase activity and cell death, at least in
part by ridding the cell of DIAP1.  However, dOmi accomplished this feat, not by
stimulating DIAP1 autoubiquitinylation, but rather by directly degrading DIAP1.
3.3 Discussion
The role of mitochondria in fly apoptosis remains highly controversial, due in
large part to disagreement over whether mitochondria undergo losses in ∆ψm and
MOMP following stress (Dorstyn et al., 2004; Kanuka et al., 1999b; Senoo-Matsuda et
al., 2005; Zimmermann et al., 2002).  Moreover, while mitochondrial release of
cytochrome c in mammalian cells initiates formation of the Apaf-1 apoptosome complex
and activation of caspases (Cain et al., 2002), there is disagreement over the importance
of cytochrome c for promoting cell death in flies (Arama et al., 2003; Arama et al., 2006;
Dorstyn et al., 2004; Mendes et al., 2006; Zimmermann et al., 2002).  The cytochrome c
debate notwithstanding, there are additional mitochondrial proteins in mammals that play
a role in promoting apoptosis, including the dual IAP antagonist and serine protease,
Omi/HtrA2 (Hegde et al., 2002; Martins et al., 2002; Suzuki et al., 2001a; Verhagen et
al., 2002).  In our studies, we set out to determine if the Drosophila homologue of Omi
might likewise participate in cell death.  We found that dOmi was highly homologous to
hOmi, particularly within the serine protease domain and that its expression was
developmentally regulated.  dOmi was imported into fly mitochondria and processed in
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situ, resulting in the removal of its MTS and exposure of two distinct IBMs.  The mature
forms of dOmi were then released into the cytoplasm following stress, through both
caspase-dependent and independent processes.  However, once in the cytosol, dOmi
induced cell death in S2 cells and in the developing fly eye, primarily through proteolytic
degradation of DIAP1 and likely other substrates.
Indeed, catalytically inactive ∆79-dOmiS266A and ∆92-dOmiS266A failed to induce
significant apoptosis, which was somewhat surprising given that both forms of dOmi
selectively bound to the BIR2 domain in DIAP1 and displaced the initiator caspase
DRONC.  In particular, the affinity of ∆79-dOmi for BIR2 (Kd ~0.27 µM) was lower than
that observed for Rpr-IBM (Kd ~0.036 µM), but was slightly higher than that observed
for mature Smac with XIAP-BIR3 (Kd ~0.42 µM) (Liu et al., 2000; Wu et al., 2001).  So
why did dOmi require its proteolytic activity to induce cell death, rather than inducing
rapid IBM-dependent apoptosis?  Notably, unlike other fly IAP antagonists, which
exhibit partial preference for either the BIR1 or BIR2 domains, dOmi completely failed
to bind the BIR1 domain in DIAP1 and did not displace the active effector caspase
DrICE.  Thus, it is possible that the continued inhibition of DrICE by DIAP1 was
sufficient to inhibit cell death.  There is precedence for such a scenario in mammals, as
we have previously shown that XIAP mutants that fail to bind and inhibit caspase-9 can
still prevent apoptosis through inhibition of caspase-3 alone (Bratton et al., 2002).
One of the primary differences between fly and mammalian IAP antagonists
relates to their abilities to independently induce apoptosis.  Indeed, Rpr, Hid, and Grim
induce robust cell death in both cultured cells and flies (Kornbluth and White, 2005),
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whereas overexpression of mature Smac in the cytoplasm of mammalian cells generally
fails to induce apoptosis in the absence of an accompanying prodeath stimulus (Creagh et
al., 2004; Du et al., 2000).  A potential explanation for these results may involve their
relative capacities to induce RING-dependent autoubiquitinylation upon binding to IAPs.
Indeed, while many IAP antagonists in the fly induce DIAP1 autoubiquitinylation, Smac
appears to suppress XIAP autoubiquitinylation (Creagh et al., 2004).  In our studies,
dOmi failed to induce or suppress DIAP1 autoubiquitinylation upon binding to its BIR2
domain.  Thus, in the absence of dOmi’s proteolytic activity, DIAP1 may again be free to
maintain its inhibition of DrICE via its BIR1 domain.  By contrast, given that DIAP1 can
protect cells by targeting active DRONC for proteosomal degradation, it is also plausible
that DIAP1 might regulate cell death in part by promoting the turnover of dOmi.  Hay
and colleagues have previously reported that the DIAP1-binding mutant, DRONC
(F118E), induces significantly more cell death than wild-type DRONC, when expressed
in the developing fly eye (Chai et al., 2003a), and correspondingly, we found that ∆92-
dOmi consistently produced a more severe phenotype than ∆79-dOmi, in accordance with
their relative affinities for DIAP1.
Others have reconciled such differences between the mammalian and fly IAP
antagonists by arguing that, in contrast to the Apaf-1•caspase-9 apoptosome complex, the
DARK•DRONC apoptosome complex is constitutively active.  Consequently, DIAP1 is
required to continuously ubiquitinylate DRONC and mediate its turnover in order to
prevent cell death (Muro et al., 2002).  In this model, Rpr, Hid, or Grim need only
displace this active DRONC in order to promote the activation of effector caspases and
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induce apoptosis.  However, recent studies suggest that, at least for Rpr and Grim, the C-
terminus of these IAP antagonists play important roles in promoting both mitochondrial
injury and/or inhibition of protein translation (Claveria et al., 2002; Holley et al., 2002).
These alternative functions for Rpr and Grim may be necessary to first initiate caspase
activation, after which the IBMs serve to displace these active caspases from DIAP1.
Therefore, it could be that binding of dOmi to DIAP1-BIR2 per se does not induce
apoptosis, because in the absence of another stimulus, there may be very little active
DRONC to displace.  In any event, regardless of whether dOmi induces cell killing solely
through its proteolytic activity, or functions as a pure IAP antagonist in certain contexts,
our studies suggest that mitochondria may play a far more important role in apoptosis in
the fly than previously thought.
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Chapter 4: Caspase cleavage of DIAP1 promotes N-end rule-dependent
trans-ubiquitination and degradation of the IAP antagonist Grim
4.1 Introduction
Apoptosis is an evolutionarily conserved process required during development
and for maintaining normal tissue homeostasis (Budihardjo et al., 1999).  A group of
cysteinyl aspartate-specific proteases (caspases) are the chief executioners of apoptosis.
In response to apoptotic stimuli, the initiator caspases that are distinguished by the
presence of long prodomains are activated.  Active initiator caspases cleave and thereby
activate downstream effector caspases, which in turn cleave several cellular substrates
thus leading to apoptosis (Riedl and Salvesen, 2007).  IAPs are one of the key regulators
of apoptosis and modulate cell death by inhibiting caspase activity.  In general, IAPs are
defined by the presence of one or more BIR domains, which are required for their
interactions with proapoptotic proteins like caspases.  Most IAPs also have a C-terminal
RING-domain which functions as an E3 ligase (Salvesen and Duckett, 2002). The
inhibition of caspase activity by IAPs is neutralized by IAP antagonists, which are
characterized by the presence of an N-terminal tetra-peptide IAP binding motif (IBM).
IAP antagonists negate the function of IAPs by binding to the BIR domains and thereby
displacing the bound caspases (Vaux and Silke, 2003).
In Drosophila, the initiator and effector caspases, Dronc and DrICE, respectively,
play important roles in regulating apoptosis (Fraser et al., 1997; Quinn et al., 2000).  The
Drosophila IAP 1(DIAP1), which contains two BIR domains and a C-terminal RING
domain, regulates the activity of caspases (Kaiser et al., 1998; Meier et al.,
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2000)(Illustration 1.4).  Animals null for DIAP1 show increased caspase activation and
exhibit embryonic lethality (Hay et al., 1995; Yoo et al., 2002).  Similarly, RNAi of
DIAP1 in Drosophila S2 cells triggers spontaneous and unrestrained caspase activation
resulting in massive apoptosis (Yokokura et al., 2004; Zimmermann et al., 2002).  DIAP1
binds through its BIR2 domain to Dronc and induces RING-dependent ubiquitination and
degradation of Dronc (Chai et al., 2003a; Wilson et al., 2002).  Consequently, cell death
caused by over expression of Dronc is enhanced in a DIAP1-RING domain mutant
background (Wilson et al., 2002).  DIAP1 also inhibits the activity of effector caspases
such as DrICE and DCP-1 by binding through its BIR1 domain (Tenev et al., 2005; Yan
et al., 2004b).  The pro-apoptotic IAP antagonists Reaper (Rpr), Hid, and Grim (RHG
proteins) remove the inhibition of caspases by DIAP1 (Wang et al., 1999).  The RHG
proteins, through their N-terminal IBMs, bind to the BIR domains in DIAP1 and displace
the bound caspases (Chai et al., 2003a; Tenev et al., 2005; Yan et al., 2004b; Zachariou et
al., 2003).  The RHG proteins can displace caspases bound to the BIR domains because
they exhibit higher affinity for binding DIAP1.  The RHG proteins exhibit differential
interactions with the BIR1 and BIR2 domains of DIAP1 (Zachariou et al., 2003).  Reaper
and Grim can bind to both the BIR domains of DIAP1, whereas Hid preferentially binds
to the BIR2 domain (Yan et al., 2004b; Zachariou et al., 2003) (Illustration 1.4). DIAP1
in turn regulates the function of the RHG proteins through its RING domain. When
bound to DIAP1, the RHG proteins are subjected to ubiquitin-mediated degradation by
the RING domain (Olson et al., 2003b).
The RING domain of DIAP1, apart from regulating the levels of RHG proteins,
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also plays an important role in maintaining its own stability.  Similar to other RING
domain containing proteins, DIAP1 undergoes autoubiquitination in a RING domain-
dependent manner (Yoo et al., 2002).  The autoubiquitination rates are further enhanced
upon binding of the RHG proteins to the DIAP1 (Ryoo et al., 2002; Yoo et al., 2002).  In
addition to autoubiquitination, DIAP1 levels are also regulated by the N-end rule-
degradation (NERD) pathway (Ditzel et al., 2003).  In the NERD pathway, the stability of
a protein is determined, based upon the amino acid residue present at the N-terminus
(Varshavsky, 2003).  In case of DIAP1, effector caspase-mediated cleavage at Asp-20
leads to the exposure of an unstable residue (Asn 21) at the N-terminus, making it a
substrate (N-degron) of NERD pathway (Ditzel et al., 2003).  Through sequential action
of N-terminal aminohydrolase (NTAN1) and Arg-RNA protein transferase (Ate1), the
Asn in converted to Asp, followed by conjugation to an Arg residue.  DIAP1 with the N-
terminal Arg is presumably recognized by an E3 ligase, such as Ubr1 (also called N-
recognin), which is required for the NERD pathway, and a proteasome-dependent
degradation of the substrate (Ditzel et al., 2003; Varshavsky, 2003) (Illustration 1.6).
The NERD pathway not only reduces the stability of DIAP1 but also regulates the
anti-apoptotic function of DIAP1 (Ditzel et al., 2003).  Animals deficient for NTAN1 and
Ate1, the loci encoding the enzymes essential for the NERD pathway, show reduced cell
death upon over expression of Hid under the GMR promoter.  Surprisingly, disruption of
the N-end rule pathway enhances the cell death caused by Rpr over expression (Ditzel et
al., 2003). These data suggest that the NERD pathway enhances the anti-apoptotic
function of DIAP1 with respect to Rpr-induced cell death but not in the case of Hid over
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expression.  This differential effect could be attributed to the binding affinities of the IAP
antagonists for the BIR domains of DIAP1 as Hid preferentially binds to the BIR2
domain (Zachariou et al., 2003).  We therefore hypothesized that the NERD pathway not
only regulates the stability of DIAP1, but also of the IAP antagonists that can bind to the
BIR1 domain of DIAP1, such as Rpr and Grim.  Therefore, we sought to investigate the
regulation of Grim by N-end rule-mediated degradation of DIAP1 in a tractable yeast
model system. We have chosen this model system for two main reasons: (1) the
mechanistic details of the N-end rule pathway are very well characterized in S. cerevisiae
and (2) previous reports have shown that RHG proteins do not cause cell death in yeast,
unlike in S2 cells, which helps in uncoupling cell death from other regulatory
mechanisms (Olson et al., 2003a; Varshavsky, 2003; Wang et al., 1999).  Since yeast do
not have IAPs with RING domains, the effects of the NERD pathway on Grim stability
can be studied without the interference of endogenous IAP-mediated degradation. In this
work we have demonstrated that Grim is trans-ubiquitinated in an N-end rule-dependent
manner when bound to the BIR1 domain of DIAP1.
4.2 Results
4.2.1 An N-degron form of DIAP1-BIR1 leads to Grim degradation.  We observed
that Grim, when expressed in Drosophila S2 cells, was rapidly degraded.  However, upon
pre-treatment with z-VAD-fmk (50 µM), a pan-caspase inhibitor, Grim levels were
stabilized, and this correlated well with a block in DIAP1 cleavage at Asp-20 (Fig. 4.1).
Previous reports indicate that caspase-mediated cleavage of DIAP1 at Asp-20 exposes a
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destabilizing N-terminal residue, Asn, resulting in formation of a N-degron (Ditzel et al.,
2003).  Since Grim can simultaneously bind DIAP1, we questioned if Grim might be
degraded by the NERD pathway in a caspase-dependent manner.  To test this hypothesis
we used DIAP1 (amino acids 21-205), which corresponds to the BIR1 fragment obtained
as a result of cleavage after residues 20 and 205 by DrICE and Dronc, respectively
(Ditzel et al., 2003; Muro et al., 2005) (Illustration 1.8).  We also reasoned that using
DIAP1 (21-205), which contains the BIR1 domain only, at least in the initial experiments
would help us to distinguish the effect of BIR1:Grim from BIR1-BIR2:Grim interactions.
In addition, it would also allow us to study the effect of the NERD pathway on Grim
stability without the influence of RING-dependent ubiquitination.  We expressed DIAP1
(21-205) (henceforth referred to as BIR1) as a fusion protein DHFR-HA-Ub-X-BIR1-
GST (Illustration 4.1), and we generated two versions of the fusion protein, containing
either a Met (M) or Arg (R) at position X (Illustration 4.1). The fusion proteins are
cleaved post-translationally after the last residue of Ub yielding equimolar amounts of an
N-terminal tracer, DHFR-HA-Ub, and X-BIR1-GST.  Based on the identity of the amino
acid at position X, a stable M-BIR1 or an R-BIR1 (a potential N-degron) is generated
(Illustration 4.1).  As expected, when expressed in yeast we observed that R-BIR1 is
rapidly degraded compared to M-BIR1 (Fig. 4.2, lanes 1 and 2).  When expressed in a
yeast strain lacking Ubr1 -the E3 ubiquitin ligase required for NERD pathway- R-BIR1
and M-BIR1 are equally stable (Fig. 4.2, lanes 3 and 4).  These data clearly indicate that
the NERD pathway degrades the N-degron form of DIAP1 in an Ubr1-dependent
manner.
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Figure 4.1 Grim stability is dependent on caspase activation.
Drosophila S2 cells were transfected with plasmid expressing C-terminally HSV-tagged
Grim under a copper-inducible promoter.  Grim expression was induced in cells pre-
treated with either zVAD-fmk (50 µM) or DMSO (vehicle), by adding CuSO4 (0.7 mM).
Thereafter, cells were collected at several time points as indicated above and further
analyzed by immunoblotting.  Expression levels of Grim (upper panel) and DIAP1
(middle panel) were analyzed by using antibodies against the HSV tag and  endogenous
DIAP1 respectively.  A non-specific band from Grim blot was used as an internal loading
control (lower panel).
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Illustration 4.1 Scheme representing the ubiquitin-fusion proteins used to
generate DIAP1 proteins with either a stabilizing or
destabilizing N-terminal residue.
The ubiquitin-fusion protein was comprised of an N-terminal mouse Dihydrofolate
reductase (DHFR), Hemagglutinin (HA)-tag, ubiquitin (Ub) K48R, BIR1 domain of
DIAP1 (21-205), and the GST tag. ‘X’ denotes the amino acid that is present immediately
after the Ub.  Once the fusion protein is translated, it undergoes processing by
deubiquitinating enzymes (DUBs) after the Ub resulting in the generation of two
fragments: DHFR-HA-Ub and X-DIAP1(21-205)-GST (X-BIR1-GST).  Based on the
identity of the amino acid ‘X’, DIAP1(21-205)-GST (X-BIR1-GST), with either a stable
or unstable N-terminal amino acid, Met (M) or Arg (R), respectively, is generated.  As
the DHFR-HA-Ub is a stable protein, it is used as a tracer to analyze the levels of protein
expression.
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Figure 4.2 N-degron form of DIAP1 is degraded in an Ubr1-dependent manner.
S. cerevisiae strains JD53 (UBR1) and JD83-1A (ubr1Δ) carrying either pDhaUb-M-
BIR1-GST or pDhaUb-R-BIR1-GST were cultured in dextrose-containing drop-out
medium until mid-log phase, and thereafter expression of ubiquitin-fusion proteins was
induced by adding 0.2 mM CuSO4.  The cells were collected at 3 hrs post-induction and
processed for immunoblotting.  The levels of the DIAP1 proteins as well as the tracer
were analyzed by immunoblotting using α-GST and α-HA antibodies, respectively.
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In vitro studies by Varshavsky’s group have shown that within a mutisubunit
protein, a subunit with an N-terminal stabilizing residue can be degraded in trans
provided that it meets the following requirements: (1) association with the N-degron
subunit (a subunit that bears a destabilizing N-terminal residue and binds to the N-
recognin), (2) presence of an internal lysine for the addition of polyubiquitin chains in an
N-recognin-dependent manner, and (3) a correct spatial conformation of trans-targeted
substrate relative to the N-degron subunit so that the lysine is a accessible for
ubiquitination (Johnson et al., 1990; Varshavsky, 1996).  However, no physiological
interactions are reported to undergo simultaneous cis- and trans-degradation in a N-end
rule-dependent manner.  So, we proceeded to test whether Grim was trans-ubiqutinated
in a similar manner when associated with the N-degron form of DIAP1 in vivo. We
therefore co-transformed yeast with two vectors: one expressing the Ub-fusion proteins,
GST, M-BIR1-GST, or R-BIR1-GST, under a copper inducible promoter, and one
expressing Grim with a C-terminal HSV tag under a GAL1 promoter.  Grim expression
was induced by growing cells in medium consisting of 2% galactose for three hours
followed by the induction of GST, M-BIR1-GST or R-BIR1-GST with 0.2 mM CuSO4.
Thereafter, at several time points, samples were taken as indicated.  In the presence of the
rapidly degrading R-BIR1-GST, the levels of Grim protein declined over time (Fig. 4.3,
top panels). However, in the presence of GST or M-BIR1-GST, the levels of Grim
remain unchanged suggesting that R-BIR1-GST (the N-degron) was required for Grim
turnover (Fig. 4.3, top panels).  In the presence of Grim, R-BIR1-GST was still degraded,
suggesting that cis-ubiquitination of the N-degron was not affected (Fig. 4.3, panels in the
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Figure 4.3 N-degron form of DIAP1 promotes trans-degradation of Grim.
JD47-13C (UBR1) strain was co-transformed with plasmids pDhaUb-GST, pDhaUb-M-
BIR1-GST, or pDhaUb-R-BIR1-GST along with pYES2-Grim-HSV.  Transformed cells
were cultured in non-inducible raffinose-containing drop-out medium until mid-log phase
and thereafter cells were transferred to galactose-containing medium to induce the
expression of Grim.  Three hours after Grim induction, 0.2 mM CuSO4 was added to the
galactose-containing drop-out medium to induce the expression of the ubiquitin-fusion
proteins.  From then on several time points were taken as indicated, and the cells were
resuspended in the SDS-loading buffer.  The samples were analyzed by immunoblotting
for the levels of Grim (anti-HSV), ubiquitin-fusion proteins (anti-GST), tracer (anti-HA),
and α-tubulin (anti-α-tubulin).
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Figure 4.4 Difference in the Grim levels are not a consequence of cell death.
JD47-13C (UBR1) strain was co-transformed with plasmids pDhaUb-GST, pDhaUb-M-
BIR1-GST, or pDhaUb-R-BIR1-GST along with pYES2-Grim-HSV.  The transformants
were cultured in non-inducible dextrose-containing drop-out medium to saturation.  Cells
were serially-diluted and spotted on to the drop-out plates containing either dextrose or
galactose in the presence and absence of 0.2 mM CuSO4.  The plates were incubated at
300C for 1-2 days and analyzed for viability.
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second row).  These observed differences in Grim levels could not be attributed to the
variation in the expression of the ubiquitin-fusion proteins, as the levels of the tracer
(DHFR-HA-Ub) were similar in each treatment (Fig. 4.3, panels in the third row).
Expression of the RHG proteins in S2 cells as well as in the fly eye has been
reported to cause extensive cell death (White et al., 1994; Yokokura et al., 2004).  To rule
out that differences in grim expression, in the presence of M- and R-BIR1-GST proteins,
was not due to cell death, we analyzed the viability of each transformant.  The viability
assays were performed by spotting serially diluted cells onto plates containing either
glucose or galactose with or without CuSO4.  Under these conditions, where Grim was
expressed alone (galactose) or in combination with the BIR1 proteins (galactose +
CuSO4) there was no difference in cell death, indicating that Grim expression does not
affect the viability of yeast (Fig. 4.4).  Thus, we concluded that the differences in Grim
expression levels were not a result of cell death, but rather were a consequence of being
degraded along with DIAP1-BIR1.
4.2.2 Grim is trans-ubiquitinated by Ubr1 on a critical lysine following their
association with DIAP1-BIR1. To verify if the degradation of Grim was dependent on
its interaction with the BIR1 domain of DIAP1 we analyzed the stability of a Grim
mutant lacking its functional IBM (GGAY-Grim) (Ala2Gly, Ile3Gly) (Fig. 4.5). The
levels of GGAY-Grim are equal in the presence of both M-BIR1-GST and R-BIR1-GST
suggesting that the interaction of Grim with BIR1 is necessary for its degradation by
NERD pathway.  As mentioned earlier, one of the major requirements of the trans-
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Figure 4.5 Trans-degradation of Grim requires its interaction with the BIR1
domain of DIAP1.
JD47-13C (UBR1) strain was co-transformed with plasmids pDhaUb-M-BIR1-GST or
pDhaUb-R-BIR1-GST along with pYES2-GGAY-Grim-HSV.  Transformed cells were
further analyzed for the expression levels of Grim (anti-HSV), ubiquitin-fusion proteins
(anti-GST), tracer (anti-HA), and α-tubulin (anti-α-tubulin) as described in the Fig. 4.3.
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targeted protein is the presence of an internal lysine residue, which can be
polyubiquitinated (Johnson et al., 1990). To check if the trans-degradation of Grim
requires an intact lysine, we analyzed the stability of Grim by mutating the only lysine at
position 136 to an alanine (Grim-K136A).  Upon co-transformation with R-BIR1-GST,
Grim-K136A was very stable relative to its wild-type version (Fig. 4.7).  This result
suggests that the degradation of Grim requires an internal lysine and is degraded
presumably in a proteasome-dependent manner.
To further ascertain whether the degradation of Grim was dependent on the N-end
rule pathway, we analyzed the loss of Grim in yeast lacking the N-recognin, Ubr1.  In the
Ubr1-/- strain, R-BIR1-GST was stable and correspondingly Grim was not degraded
(Fig. 4.6). This result suggests that both Ubr1 and the BIR1 domain of DIAP1 (in its N-
degron form) are required for trans-degradation.
4.2.3 Cleavage of DIAP1 by Dronc generated a BIR1 fragment that more readily
promotes trans-ubiqutination of Grim.   As mentioned previously, the initiator caspase
Dronc, cleaves DIAP1 after Asp-205 and this cleavage increases the anti-apoptotic
activity of DIAP1 (Muro et al., 2005) (Illustrations 1.8 and 4.2).  To further understand
the significance of the Dronc-mediated DIAP1 cleavage on Grim degradation via the
NERD pathway, we have generated a fusion protein of DIAP1 comprising both the BIR1
and BIR2 domains (amino acids 21-336), DHFR-HA-Ub-X-BIR1-BIR2-GST.  As yeast
do not have homologs of Dronc, DIAP1 is not cleaved at Asp-205, X-BIR1-BIR2-GST
was expressed in its intact form. Upon expression in yeast similar to the BIR1 domain
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Figure 4.6 Trans-degradation of Grim requires an intact lysine at position 136.
JD47-13C (UBR1) strain was co-transformed with the pYES2-Grim-HSV or pYES2-
Grim-K136A-HSV plasmids along with pDhaUb-R-BIR1-GST.  Transformed cells were
analyzed for the expression levels of Grim (anti-HSV), ubiquitin-fusion proteins (anti-
GST), tracer (anti-HA), and α-tubulin (anti-α-tubulin) as described in the Fig. 4.3.
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Figure 4.7 Trans-degradation of Grim occurs in an Ubr1-dependent manner.
JD53 (UBR1) and JD83-1A (ubr1Δ) were co-transformed with the pDhaUb-R-BIR1-GST
and pYES2-Grim-HSV plasmids.  Transformed cells were analyzed for the expression
levels of Grim (anti-HSV), ubiquitin-fusion proteins (anti-GST), tracer (anti-HA), and α-
tubulin (anti-α-tubulin) as described in the Fig. 4.3.
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in its N-degron form, R-BIR1-BIR2-GST was rapidly degraded in an Ubr1-dependent
manner by the NERD pathway (data not shown).  We then analyzed for the stability of
Grim in the presence of DIAP1 with BIR1 or both BIR1 and BIR2 domains (R-BIR1-
GST and R-BIR1-BIR2-GST).  To our surprise, in contrast to R-BIR1-GST, Grim was
not degraded in the presence of R-BIR1-BIR2-GST (Fig. 4.8).  We reasoned that the
inability of Grim to be trans-ubiquitinated in the presence of DIAP1, containing both its
BIR domains, could be due to its distributed binding to both BIR1 and BIR2 domains.
To test this hypothesis, we generated a mutant form of R-BIR1-BIR2-GST (G269S),
which impairs proper binding of the IAP antagonists to the BIR2 domain thus forcing
most of the Grim to bind to the BIR1 domain.  However, even in the presence of the
G269S mutation Grim was not degraded (McGonigal, thesis in preparation). These data
suggests that Grim, can only be degraded by DIAP1 following cleavage as Asp-20 and
Asp-205 by Drice and Dronc, respectively.  Presumably, binding of Grim to DIAP1-
BIR1 domain, obtained as a result of Dronc cleavage, may make Grim accessible for
ubiquitination in an Ubr1-dependent manner.
4.3 Discussion
It has previously been reported that the caspase-mediated cleavage of DIAP1 at its
N-terminus makes it a target for the NERD pathway.  Surprisingly the degradation of
DIAP1 through the NERD pathway enhances its anti-apoptotic activity, despite the
decrease in its stability, with respect to Rpr-induced cell death (Ditzel et al., 2003).  We
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Figure 4.8 Trans-degradation of Grim requires binding to BIR1 domain of
DIAP1 only.
JD47-13C (UBR1) strain was co-transformed with plasmids pDhaUb-R-BIR1-GST or
pDhaUb-R-BIR1-BIR2-GST along with pYES2-Grim-HSV.  Transformed cells were
further analyzed for the expression levels of of Grim (anti-HSV), ubiquitin-fusion
proteins (anti-GST), tracer (anti-HA), and α-tubulin (anti-α-tubulin) as described in the
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hypothesized that one of the possible mechanisms by which the NERD pathway
enhanced the anti-apoptotic function of DIAP1 was by promoting the degradation of pro-
apoptotic proteins bound to it (Illustration 4.2).  In contrast to Rpr-induced cell death, the
NERD pathway enhances the cell death caused by expression of Hid (Ditzel et al., 2003).
These observations led us to speculate that the disparate effects of the NERD pathway on
Reaper and Hid-induced cell death could be based on their differential binding affinities
for the BIR1 and BIR2 domains and that only the pro-apoptotic proteins that bound to the
BIR1 domain could be regulated by the NERD pathway (Illustration 4.2). To test this
possibility, we studied the effects of the NERD pathway on Grim, a pro-apoptotic IAP
antagonist that can bind to both the BIR1 and BIR2 domains.
In our study, using yeast, we have shown that Grim, when bound to the BIR1
domain of DIAP1, is trans-ubiquitinated by Ubr1 and degraded by the NERD pathway
(Figs. 4.3 and 4.5).  The degradation of Grim requires an intact lysine, which is required
for polyubiquitination in an Ubr1-dependent manner (Figs. 4.6 and 4.7).  Thus, we have
demonstrated for the first time in vivo that a protein with a stable N-terminal residue can
indeed be trans-targeted provided that it is in complex with an N-degron (Illustration
4.2).  Our data also sheds significant light on the underlying contribution of the NERD
pathway to the anti-apoptotic function of DIAP1.  Despite its degradation by the N-end
rule pathway, DIAP1 still maintains its anti-apoptotic activity by facilitating the
degradation of Grim.  Based on our data, we speculate that the NERD pathway may
degrade other pro-apoptotic proteins, such as Reaper and DrICE that bind to the BIR1
domain of DIAP1 (Illustration 4.2).
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Illustration 4.2 Model depicting the mechanisms involved in the ubiquitin-
mediated degradation of the pro-apoptotic proteins by DIAP1.
DIAP1 acts as a substrate for both the initiator and effector caspases, Dronc and DrICE,
respectively.  Cleavage by DrICE alone leads to the removal of N-terminal twenty amino
acids (Δ20-DIAP1) (left scheme).  On the other hand, cleavage by both the caspases leads
to generation of two entities: an N-degron form of BIR1 domain and BIR2-RING
module.  The N-degron form of BIR1 degrades pro-apoptotic proteins such as Rpr, Grim,
and DrICE in an Ubr1-dependent manner (right scheme).  However, binding of the RHG
proteins as well as DrICE to the Δ20-DIAP1 does not facilitate their degradation in the
NERD pathway-dependent manner.
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 It has previously been suggested that the lysines at positions 10 and 15 from the
N-terminus of an N-degron are critical for ubiquitination by the N-recognin (Suzuki and
Varshavsky, 1999).  But recent data suggest that the lysines at position 30 and 35 of
DIAP1, which correspond to the Lys-10 and –15 of the N-degron, are not responsible for
for the degradation of DIAP1 by the NERD pathway (Herman-Bachinsky et al., 2007).
Our data was in agreement with these observations suggesting that the lysines at positions
49, 61, 77 and 79, which are a part of the BIR1 domain, could be the putative
polyubiquitination sites for the degradation of BIR1 domain.  Further insights can be
obtained once we have a better understanding of the exact mechanism(s) by which
DIAP1 is degraded by Ubr1.
Interestingly, our data suggest that in contrast to the DIAP1-BIR1, DIAP1-BIR1-
BIR2 is incapable of trans-ubiquitinating Grim for degradation (Fig. 4.8).  Initially, we
hypothesized that the reason for Grim stability could be attributed to its distributed
binding to both the BIR1 and BIR2 domains, which positions only a portion of Grim in
close proximity to Ubr1.  However, forcing most of the Grim to bind to the BIR1 domain
by mutating Gly-269 to Ser did not enhance the trans-ubiquitination of Grim
(McGonigal, thesis in preparation).  This argues that cleavage of DIAP1 by Dronc at
Asp-205 is essential for targeting Grim for degradation by the NERD pathway.  One of
the possible explanations for this result could be that the BIR1 domain, unlike DIAP1,
which contains both BIR domains, orients Grim in a conformation that supports
polyubiquitination by the Ubr1.  These data are also in agreement with previous data,
which suggests that cleavage of Dronc enhances its anti-apoptotic activity (Muro et al.,
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2005). Therefore, cleavage of DIAP1 by both DrICE and Dronc creates two entities of
DIAP1, which differentially degrade pro-apoptotic proteins either through the NERD
pathway or through RING-dependent ubiquitination.  Previous work by Yokokura et al.
(2004) suggested that RING-dependent ubiquitination takes precedence over N-end rule
pathway.  As Dronc cleavage of DIAP1 separates the BIR1 domain from the influence of
RING domain, it can be argued that RING-dependent ubiquitination overrides N-end rule
pathway only in the uncleaved state (Illustration 4.2).  It will be interesting to see if
Dronc-dependent cleavage of DIAP1 also enhances ubiquitination by the RING domain.
In summary, we have shown that Grim is trans-ubiquitinated by the NERD
pathway in a caspase-dependent manner (Fig 4.3).  However, it remains unclear if a
similar mechanism exists for DrICE.  We have also shown that degradation of DIAP1 by
the NERD pathway occurs in an Ubr1-dependent manner (Fig 4.6).  But, it still remains
to be determined if Ubr1 directly ubiquitinates the trans-targeted proteins or if it recruits
other E3 ligases for this task.  Gaining further insight will help us understand a novel
mechanism by which IAPs regulate the IAP antagonists.
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Chapter 5: Concluding remarks
Apoptosis is essential for normal development and maintenance of tissue
homeostasis (Opferman and Korsmeyer, 2003).  It is an evolutionarily-conserved form of
cell death with many common players in different organisms such as C. elegans,
Drosophila, and mammals (Kornbluth and White, 2005).  In C. elegans, the regulatory
network is rather simple with four main players: (1) CED-3, a cysteine protease
(caspase), (2) CED-4, the adaptor protein, (3) EGL-1, the pro-apoptotic Bcl-2 family
member, and (4) CED-9, the anti-apoptotic Bcl-2 family member (Lettre and Hengartner,
2006).  Disruption of the CED-9:CED-4 interaction by EGL-1 is required to initiate the
apoptotic pathway, and CED-4, subsequently binds to and activates CED-3.  Once
activated, CED-3 then cleaves several cellular substrates resulting in apoptosis (Lettre
and Hengartner, 2006).  In mammals, similar core components including caspases
(mammalian homologs of CED-3), the adaptor protein Apaf-1 (mammalian homologs of
CED-4), and Bcl-2 family members regulate apoptosis (Jiang and Wang, 2004).  In
contrast to C. elegans, mammalian Bcl-2 family members contribute to caspase activation
by regulating MOMP, rather than directly binding to Apaf-1 (Danial and Korsmeyer,
2004).  As a consequence of MOMP, cytochrome c is released into cytosol, where it
induces formation of the apoptosome, an oligomeric complex that acts as a platform for
the activation of caspases (Riedl and Salvesen, 2007).  In mammals, IAPs and IAP
antagonists impart a second layer of caspase regulation (Salvesen and Duckett, 2002).
IAPs bind to and inhibit active caspases whereas IAP antagonists displace IAP-bound
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caspases (Salvesen and Duckett, 2002).  The Drosophila apoptotic regulatory machinery
is very similar to that of mammals consisting of caspases, Dark (fly homolog of
mammalian Apaf-1), Bcl-2 family members, IAPs, and IAP antagonists (Hay and Guo,
2006).  Despite several similarities, key differences exist between mammalian and fly cell
death mechanisms (Kornbluth and White, 2005).  Therefore, gaining further insights into
the Drosophila apoptotic mechanisms is essential to understand the evolutionarily-
conserved nature of this process.
One of the unresolved questions regarding Drosophila apoptotic mechanisms is
the role of mitochondria in caspase activation.  As mentioned earlier, MOMP and the
subsequent release of cytochrome c are prerequisites for the activation of mammalian
initiator caspase-9 (Riedl and Salvesen, 2007).  Moreover, release of the mammalian IAP
antagonists into cytosol, regulates caspase activity by inhibiting the function of IAPs
(Vaux and Silke, 2005). There is also evidence demonstrating that cytochrome c is
required for caspase activation in flies in a tissue-specific manner (Arama et al., 2003;
Arama et al., 2006).  However, several lines of evidence suggest that activation of Dronc,
the fly homolog of mammalian caspase-9, occurs independent of MOMP and cytochrome
c release (Dorstyn et al., 2004; Means et al., 2006; Muro et al., 2002; Zimmermann et al.,
2002). Additionally, the cytosolic localization of Drosophila IAP antagonists Rpr, Hid,
and Grim undermine the role of mitochondria in fly apoptosis further strengthening this
controversy (Kornbluth and White, 2005).  Therefore, in order to gain a better
understanding of mitochondrial function in Drosophila apoptosis, we identified and
characterized the role of dOmi, a fly homolog of the mammalian IAP antagonist
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Omi/Htra2 (chapter 3).  We have demonstrated that various apoptotic stimuli such as STS
and UV irradiation can induce MOMP and thereby cause the release of both dOmi and
cytochrome c into the cytosol.  Once released, the mature forms of dOmi potentiate cell
death primarily through their protease activities.  The role of cytochrome c will require
further characterization.  Nevertheless, we observed that based upon the nature of the
apoptotic stimulus, MOMP occurs either in a caspase-dependent or -independent manner.
This is not surprising as even in mammals, MOMP can occur either prior to or after
caspase-9 activation depending on the stimulus.  For instance, in the intrinsic pathway,
MOMP is required for apoptosome formation and subsequent caspase-9 activation (Jiang
and Wang, 2004).  On the other hand, following death receptor stimulation, activation of
caspase-8 leads to MOMP, which in turn leads to caspase-9 activation (Budihardjo et al.,
1999).  Therefore, our data suggests that in Drosophila, similar to mammals, MOMP can
occur either in a caspase-dependent or -independent manner.
Although we have successfully established that Drosophila mitochondria can be
permeabilized upon the receipt of an apoptotic stimulus, the factors that contribute to this
process are yet to be determined.  It will be interesting to see if the Drosophila Bcl-2
family members, Debcl and Buffy, similar to their mammalian counterparts, modulate
MOMP and subsequent release of mitochondrial resident proteins, such as cytochrome c
and dOmi, into the cytosol (Danial and Korsmeyer, 2004; Igaki and Miura, 2004).  Apart
from the Bcl-2 family members, the GH3 domain of IAP antagonists like Reaper and
Grim also plays an important role in mitochondrial permeabilization (Claveria et al.,
2002; Olson et al., 2003a).  It will be interesting to see if GH3 domain-dependent
128
mitochondrial permeabilization can cause release of dOmi and cytochrome c. Therefore,
it could be speculated that dOmi plays an important role in further enhancing the GH3-
dependent cell death mechanisms.  Additional characterization of the role of Drosophila
Bcl-2 family members and the GH3 containing IAP antagonists in regulating MOMP
should enhance our understanding of the role of mitochondria in fly apoptosis.  With
respect to caspase-dependent MOMP, the identity of the caspases, as well as their
substrates required for mitochondrial permeabilization, remains to be determined.
We have demonstrated that dOmi, once released into cytosol, enhances caspase
activity and potentiates cell death.  However, RNAi of dOmi does not completely inhibit
caspase activation.  These data suggest that apart from dOmi, other pro-apoptotic
molecules that are released into the cytosol as a consequence MOMP may also contribute
to caspase activation.  As cytochrome c can bind to the WD40 repeats of DARK (Kanuka
et al., 1999b), it remains a possibilty that some of the caspase activity observed upon
MOMP may be attributed to apoptosome-dependent Dronc activation. Further studies
using RNAi approaches are required to study the effects of cytochrome c, Dronc, and
Dark on caspase activation following MOMP.  In the case of mammals, a redundancy
exists with respect to the number of mitochondrial IAP antagonists (Vaux and Silke,
2005).  Thus, caspase activation in the fly could also be due to other unknown IAP
antagonists that are released into cytosol following MOMP.  Identification and
characterization of other mitochondrial pro-apoptotic molecules would certainly reinforce
the role of mitochondria in Drosophila apoptosis.
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In Drosophila, loss of DIAP1 triggers spontaneous and unrestrained caspase
activity, suggesting that, unlike in mammals, IAPs act upstream of caspases (Yoo et al.,
2002; Zimmermann et al., 2002).  The caspase activation that occurs as a consequence of
DIAP1 depletion also requires the adaptor protein, Dark.  These observations have led to
the proposal that the Drosophila apoptosome is constitutively active and that
displacement of DIAP1-bound Dronc is sufficient to trigger caspase activation without a
prior requirement for MOMP (Kornbluth and White, 2005).  In support of this
hypothesis, expression of the cytosolic RHG proteins can trigger cell death.  However,
cytosolic expression of the catalytically inactive mature forms of dOmi, that are capable
of displacing BIR2 domain-bound Dronc, could not potentiate cell death.  Therefore, our
results suggest that mere displacement of DIAP1-bound Dronc by dOmi is not sufficient
to potentiate fly apoptosis.  One potential explanation for this discrepancy is that the
RHG proteins apart from displacing DIAP1-bound caspases, also play an important role
in mitochondrial permeabilization (Abdelwahid et al., 2007; Chai et al., 2003a; Yan et al.,
2004b).  In addition, Reaper and Grim play an important role in translational inhibition
(Colon-Ramos et al., 2006; Holley et al., 2002). Therefore, cell death caused by over
expression of RHG proteins could be a manifestation of its multiple functions, including,
caspase-displacement, mitochondrial permeabilization, and translational suppression.
Thus, relying upon the ability of RHG proteins to cause cell death as evidence for a
constitutively active apoptosome needs to be reconsidered.
Recent structural data of the Drosophila apoptosome has often been cited as
evidence for a lack of mitochondrial involvement in fly cell death mechanisms.  The
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structural data demonstrates that the fly apoptosome is an octameric RING-like structure
and is formed in the absence of cytochrome c (Yu et al., 2006).  However, several
questions regarding the fly apoptosome remain unanswered.  In mammals, binding of
cytochrome c to the WD-40 repeats is a prerequisite for oligomerization, as it results in
an altered conformation of the monomeric Apaf-1 and leads to the formation of the
heptameric structure (Riedl and Salvesen, 2007). The structural data for the fly
apoptosome does not provide a mechanistic explanation for oligomerization.
Additionally, the functionality of the proposed structure is yet to be determined.  In vitro
reconstitution experiments will be required to determine if the octameric Drosophila
apoptosome can lead to the activation of Dronc.  Additionally, it will be interesting to see
if endogenous Dark exists in an oligomeric state without an apoptotic stimulus. Even if
cytochrome c is not required for formation of the Drosophila apoptosome, it does not
preclude the role of mitochondria in fly cell death mechanisms.  It is possible that another
mitochondrial molecule(s) may substitute for cytochrome c in promoting formation of the
fly apoptosome.  Therefore, identifying and characterizing putative molecules that
interact with Dark will be crucial in corroborating the role of mitochondria in Drosophila
apoptosis and will further our understanding of the mammalian apoptosome.
Similar to its mammalian counterpart, dOmi potentiates cell death mainly through
its serine protease activity.  We have demonstrated that DIAP1 is a dOmi substrate and
that degradation of DIAP1 contributes to the caspase activation.  However, dOmi
potentiates cell death through both caspase-dependent and -independent mechanisms.
These data suggest that dOmi can potentiate cell death by cleaving additional cytosolic
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substrates.  Therefore, identifying other cytosolic substrates of dOmi, using a
combination of genetic and biochemical techniques, will aid in understanding the
complete role of dOmi in promoting cell death.
Omi/HtrA2 plays a neuroprotective role and loss of its protease function results in
mice with neurodegenerative and Parkinsonian symptoms (Jones et al., 2003; Martins et
al., 2004).  In addition, mutations in Omi/HtrA2 have been linked to German patients
with Parkinson’s disease (Strauss et al., 2005).  Therefore, it will be important to better
understand the mechanisms by which Omi/HtrA2 contributes to the survival of neurons.
Identifying the intermembrane space substrates is also essential for understanding
Omi/HtrA2’s role in mitochondria.  The Drosophila model system should also serve as a
good model system to study dOmi’s mitochondrial functions.
Similar to dOmi, cleavage of DIAP1 by caspases also regulates the stability and
function of DIAP1 (Ditzel et al., 2003; Muro et al., 2005).  Cleavage by DrICE at Asp-20
transforms DIAP1 into a substrate for the NERD pathway, thereby reducing its stability.
Interestingly, loss of DIAP1 by the NERD pathway enhances its anti-apoptotic pathway
with respect to Rpr-induced cell death (Ditzel et al., 2003).  So far the mechanisms by
which the NERD pathway modulates DIAP1 function remain unknown.  We have
demonstrated that Grim, when bound to the BIR1 domain in DIAP1, is trans
ubiquitinated by NERD pathway.  Our data suggest that similar to RING domain-
dependent ubiquitination, the NERD pathway also regulates the stability of some pro-
apoptotic proteins.  Although, we have only demonstrated the effect of the NERD
pathway on Grim, its influence on Rpr, Hid, and DrICE should be studied.  Interestingly,
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we observed that the BIR1 domain of DIAP1, formed as a result of DRONC cleavage,
efficiently degrades Grim in an N-end rule-dependent manner when compared to full-
length DIAP1.  We hypothesize that binding of Grim to the BIR1 fragment of DIAP1
orients it for trans-ubiquitination by Ubr1, the E3 ubiquitin ligase of the NERD pathway.
Based on these data, we speculate that Dronc cleavage may also enhance RING-
dependent ubiquitination of the RHG proteins bound to the BIR2 domain.  Studying the
kinetics of RING-dependent degradation of RHG proteins, in the presence of either full-
length or cleaved forms of DIAP1, will be required to understand the significance of
Dronc cleavage.
The role of NERD pathway in the regulation of apoptosis has been reported only
in Drosophila (Ditzel et al., 2003).  However, its role in mammalian apoptotic pathways
is currently under investigation.  Based on the knowledge gained from fly model, we
hypothesize that cleavage of various substrates by caspases may convert them from pro-
N-degron to N-degron forms.  If so, rapid loss of caspase substrates may enhance the
rateof cell death.  As mentioned previously, an Alanine residue at the N-terminus of a
protein is considered stable with respect to the NERD pathway in yeast (Varshavsky,
1996).  However, in mammals, an N-terminal Alanine is a destabilizing residue.  Based
on this, we speculate that the NERD pathway may also regulate the stability of
mammalian mitochondrial IAP antagonists, characterized by an N-terminal Alanine, once
they are released into cytosol.  Thus, the role of NERD pathway in the degradation of
mammalian IAP antagonists should be investigated.
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In conclusion, we have studied the regulation of DIAP1 function by dOmi and the
NERD pathway.  By implicating dOmi in DIAP1 regulation we have underscored the
importance of mitochondria for apoptosis in the fly.  Through our N-end rule studies we
have demonstrated a novel regulation of the IAP and IAP antagonist function.  Despite
our contributions, there are still many more interesting questions that remain unanswered
which will enhance our understanding of the evolutionarily-conserved apoptotic process.
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